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Summary 
The concentration of paxillin in the nucleus is dramatically increased by the 
inhibition of nuclear export by LMB.    Since paxillin is a major focal adhesion marker, 
we tested the effect of altering adhesion strength by altering the morphology of the 
cells. Cell geometry was modified by using circular or triangular micropatterned 
fibronectin islands. On circular substrates, with  more dynamic  adhesions,  the  
concentration  of  paxillin  in  the  nucleus  was  increased. Conversely on triangular 
patterns, with stable adhesions, paxillin had reduced nuclear paxillin, indicating a 
dependence on adhesion strength.  Looking at proteins that contributed to adhesion 
strength, we found that the deletion of vinculin and FAK caused a dramatic increase in 
nuclear concentration of paxillin.  An  overexpression  of  FAK  caused  a  drop  in  
paxillin’s  nuclear  accumulation.  To understand which domains might be involved  
we overexpressed FAK with a double mutation in the  paxillin  binding  FAT  region,  
I936/I998,  which  did  not  affect  paxillin’s  nuclear  translocation. Transfection of 
just the FAT domain dramatically inhibited nuclear concentration. Moreover presence 
of excess FAT domain also prevented paxillin recovery in FRAP studies. We suggest 
that paxillin acts as a long term signal for cell adhesion, and increased nuclear transport 
acts as a signal for cell proliferation and is dependent upon focal adhesion turnover.  
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1. Introduction 
Focal adhesions (FA) are structures that not only help the cell adhere to the 
substrate but also play a key role in sensing mechanical input. Paxillin is one of the 
earliest proteins recruited to FA where it acts as a scaffold. Despite being one of the 
best studied molecules, Paxillin’s nuclear transport mechanism remains a mystery. 
Much is known about paxillin’s role at the focal adhesions and recent discoveries have 
shed light on its nuclear activity [1]. As focal adhesions respond to force and changes 
in the extracellular matrix (ECM) it is likely that paxillin’s nuclear transport acts as a 
biochemical cue for a physical signal. In this study, we sought to understand the 
connection between physical processes and biochemical responses by probing the 
nuclear transport of paxillin. By controlling cell geometry along with mutational 
analysis we have found that paxillin’s nuclear transport is dependent on FA turnover 
and association with the focal adhesion targeting (FAT) domains. 
Focal adhesions are now well established as sensors of mechanical forces [2]. 
Signals such as shear, tension, traction, compression, and geometry are converted into 
mechanical signals via focal adhesions and its associated interactome [3].The 
downstream effectors are controlled via GTPases of the Rho and Ras families, calcium, 
reactive oxygen species and NFκB signaling[4, 5]. This network of signals controls a 
diverse set of cell functions such as transcription, cell migration, differentiation and 
proliferation. Paxillin sits at  the center of this network serving as a scaffold protein, 
commanding its own interactome[6].  
Paxillin’s role as a scaffold provides interfaces for a wide range of proteins.  
These include Integrin Linked Kinase (ILK), Src, Focal Adhesion Kinase (FAK), 
vinculin, Mitogen-activated protein kinase (MAPK) among several others. These 
interactions control MAPK signaling, matrix organization, cell motility and gene 
expression[6]. The interaction between FAK, vinculin and paxillin is dependent upon 
myosin II activity and possibly also affects paxillin phosphorylation [7-9]. FAK targets 
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paxillin via a FAT domain, vinculin has a homologous domain which is also used for 
FA targeting [10]. Nascent FA are stabilized by vinculin possibly by providing early 
links to the actin cytoskeleton [8]. FAK phosphorylates paxillin in a cell adhesion 
dependent manner which then affects paxillin’s interactions with other proteins like 
Crk and Ras GAP[6]. 
Interactions with other proteins and paxillin are further controlled by the 
multiple tyrosine, serine and threonine phosphorylation sites present on paxillin. These 
sites serve as mediators between paxillin’s interactions with multiple membrane 
receptors and signaling molecules. These interactions allow the cell to respond in 
multiple ways to incoming input (Figure 1). Thus, paxillin a very important molecule 
in the mechanotransduction pathways.  
Paxillin is essential for survival as the knocking out of paxillin is lethal at the 
embryonic stages. Paxillin may control cell proliferation by controlling the 
transcription of the H19 gene[1]. Due to its interaction with the E6 protein of the 
papilloma virus paxillin has also been implicated in cervical cancer. The complexity of 
interactions and its role in several diseases highlights the importance of understanding 
the mechanism behind the nuclear transport of paxillin.  
 
Figure 1 Paxillin Signaling:  
Paxillin is associated directly and indirectly with multiple membrane receptors. Paxillin 
acts as scaffold connecting different pathways and controlling responses like focal 
adhesion assembly, cell motility, and gene expression. This ability to control different 
activities makes paxillin an important player for enabling multiple responses in the cell.  
(Adapted from [11])  
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1.1 Mechanotransduction  
A cell locates itself in the body using a sort of coordinate system of 
environmental signals. Indeed, if a cell realizes that its environment does not match its 
internal programming the default step is apoptosis, failing which can result in 
cancerous growth. Hormones, growth factors and other chemical signals have been 
traditionally used to study cellular responses. In recent decades it has become obvious 
that the physical cues are just as important as the chemical cues. As an example, a stem 
cell can be nudged into either adipogenesis or osteogenesis by varying the cell 
geometry alone [12]. The sensing of geometry involves many layers of signaling. From 
quantifying the cell area and tension to determining what response should be elicited 
by the cell. The entire process is an example of mechanotransduction.  
Mechanotransduction, by definition, is the conversion of physical cues into 
biochemical responses [13] and occurs across a range of scales. Starting from the 
nanometer levels, where the unfolding of different protein domains is important, to 
macro-scales like muscles and lungs which use mechanical cues to effect changes at 
organ level. The scale between the molecular and organ extremes is called the meso-
scale[14]. At this scale a large number of molecular level activities are integrated and 
then interpreted as signals by the cell.  
At the cellular level there are several components are involved in the sensing 
of force (Figure 2). Cell-cell and cell-ECM adhesions give information about the direct 
environment, further supplemented by ion-channels, surface receptors and processes. 
The nucleus is equipped with ion channels, chromatin remodeling mechanisms and 
LINC complexes which give a direct feed from the cytoskeleton the nucleus [13, 15]. 
All of these inputs rely upon molecular level events such as unfolding of protein 
domains or the sensing of curvature and tension [16-19]. But each of the molecular 
level events does not count as a signal. Small signals have to be repeated over long 
periods of time to cross a signaling threshold [17]. Although biology usually keeps a 
4 
 
backup, even point mutations can sometimes affect mechanosensing leading to 
disease[20]. 
 
Figure 2 Mediators of Mechanotransduction 
The cell uses various inputs to gather mechanical information about its environment. 
From large structures like stereocilia to cell-junctions and ion channels all are 
mechano-responsive and provide input for the cell to act on. (Adapted from [13]) 
 
Diseases like cancer, cardiovascular diseases and ageing are affected by or 
show a mechanical response [21-23]. Diseases require long term changes in the cell 
behavior which necessitates signaling to the nucleus. The nucleus itself is equipped 
with tools to sense forces at different timescales. Each of these components utilizes a 
different method of transmitting the signal to the nucleus which also leads to a 
difference in latency.  On the millisecond time scale is stress wave propagation which 
utilizes stress fibers. Some of the acto-myosin cables link the focal adhesions on one 
side and the LINC (Linker of Nucleoskeleton and Cytoskeleton) complex on the other. 
The SUN complexes further link to the interior of the cell with Titin. Thus it is possible 
for a stress wave to be directly transferred to the nucleus. A slightly slower method, on 
the scale of seconds, is the translocation of molecules along cytoskeletal filaments or 
by diffusion from either adhesions or other receptors (Figure 3). The nuclear transport 
of MRTFA has been shown to depend upon the actin organization[24]. 
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Figure 3 Nuclear Mechano-signaling  
The cell is equipped with several methods for transmitting a signal to the nucleus. 
Direct stress wave propagation uses stress fibers linked to the nucleus to transmit 
signals fast. Translocation of molecules from surface receptors is slower and can take 
place either by diffusion or by traveling upon the cytoskeleton. (Adapted from [15]) 
 
However, not all signals need to go to the nucleus. Some processes such as 
focal adhesion maturation are ‘hard coded’ in a cell. The nucleus uses sustained 
signaling to bring about  long term changes in genetic response [13]. The basic unit of 
adhesion based mechanosensing is the focal adhesion.  
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1.2 Focal Adhesion 
Focal adhesions are the basic unit of signaling used to sense the properties of 
the ECM. They are plaque like structures found on the ventral surface of cultured cells, 
connecting the ECM and the cytoskeleton via integrins and actin linking molecules. 
Signaling the chemical and physical information about the substrates, focal adhesions 
also serve as anchor points for the cell to migrate or maintain structure. Besides relaying 
information, focal adhesions also exert cellular responses like matrix deformation and 
substrate remodeling.  
Although they are very complex structures, varying in composition over time 
they can be thought of as being made up of a few modules. At the exterior of the cell 
interacting directly with the ECM are integrins which serve as a basic receptor module. 
There are several different types of integrins and different alpha-beta dimers are 
recruited depending on the matrix composition. While majority of the integrins are 
involved in the linking to the matrix they have small cytoplasmic tails with which a 
number of molecules can associate. These molecules form three different domains, the 
actin polymerizing module, the actin linking module and the signaling module. 
Although each of these modules serves a different function it is not rare for a molecule 
to be part of more than one module.  All the modules are not present to begin with and 
are assembled as the focal adhesion matures (Figure 4)[2]. 
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Figure 4 A simplified focal adhesion structure  
Focal adhesions are made up of modules for different functions. Once formed, the focal 
adhesions and cytoskeleton interactions lead to signaling via small G proteins that serve 
to either strengthen or disassemble the adhesion. (Adapted from [2]) 
 
Focal adhesion maturation can be categorized in a few steps: initiation, 
clustering, growth maturation and disassembly.  Early focal adhesions are called 
nascent adhesions and are made up of a handful of members. Nascent adhesions are 
formed at the leading edge of cells and have a high rate of turnover. When nascent 
adhesions experience rearward actin flow more proteins are recruited to the adhesions 
and the structures are now called focal complexes. Association with actin cables allows 
for further maturation to focal adhesions. Focal adhesions once formed are long lived 
and often move towards the center of the cell where they are often called fibrillar 
adhesions. The disassembly of adhesions is important for cell movement.  Adhesions 
seem to be used like tracks over which the cell moves, once the cell moves and the 
adhesions are in, what is now, the rear of the cell, it is important that they disassemble. 
Allowing the cell to move forward and form new adhesions at the leading edge of the 
cell (Figure 5).  
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The leading edge of the cell is the site of the formation of nascent adhesions 
[25]. The process starts when integrin heterodimers (primarily α5β1 and αvβ3) cluster 
and bind to ligands in the ECM (like fibronectin, vitronectin, collagen, & laminin) 
along with talin. The β1and β3 integrins have different behaviors. The β1 integrins are 
much more stable with a catch-bond like behavior and making up the force bearing 
component [26-28]. On the other hand β3 integrins are less stable but initiate and 
reinforce FA in a complex with talin. Talin mediates the interaction between FA and 
the actin cytoskeleton which then further stabilize ECM binding[29]. Recruiting of 
more early FA members like paxillin, FAK, Src-family kinases to integrin tails serves 
to further stabilize the focal adhesion. 
 
Figure 5 Stages of focal adhesion maturation  
Focal adhesion assembly starts at the leading edge of the cell where the flow of actin 
causes integrins to engage and cluster into small structures called nascent adhesions. 
Nascent adhesions undergo rapid turnover while a few link to the actin cytoskeleton 
and mature focal adhesions. These are long lived structures connected by stress fibers. 
The disassembly of mature focal adhesions takes place towards the rear of the cell 
which is signaled by local GEF depletion. (Adapted from [30]) 
 
In the context of this study, it is useful to note that that increased cytoskeletal 
stretching leads to stronger binding between FAK and paxillin [31, 32] and that paxillin 
recruitment to FAs is force dependent [7, 8]. Next, the conversion of Rac1-GDP to 
Rac1-GTP then activates formins and the ARP2/3 complex, which then nucleate actin 
and cause the growth of actin filaments. Myosin-II contraction causes the clustering of 
the associated integrins, which then move towards the center of the cell. Focal 
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complexes at this point are small (0.5-1 µm) with a short lifetime of about 80s. They 
undergo fast assembly and disassembly and the maturation into focal adhesions 
depends on the force experienced and on the stiffness of the substrate[33]. The forces 
at the leading edge are typically in the range of 5nN/µm2 [34]. Recruitment of proteins 
to maturing focal adhesions is both positively and negatively regulated by contraction 
[35]. Thus, the maturation of nascent focal adhesions depends upon force, local 
differences in the substrate and internal signaling.  
Mature FA are about 1-5µm in length and are made up of over 150 
proteins[36]. The focal adhesion is about 40nm in height and can be thought of as 
containing several layers each with a specific function [37] (Figure 6). The integrin 
signaling layer is about 20nm deep, made up of proteins that bind integrins, like 
paxillin, FAK and other signaling molecules. The force transducing layer connects the 
integrins and actin and is in the range of 20-40nm deep. Present in this layer are 
vinculin, which has indirect association with integrins, and talin which directly 
connects actin and integrins. Shared between the force transduction layer and the actin 
regulatory layer are zyxin and VASP which help control maturation. Zyxin acts as a 
marker of mature FA. About 100nm into the cell is the actin stress fiber made up of 
actin, and α-actinin [37]. From a signaling point of view, FA maturation increases the 
activity of Rho GTPases and tyrosine kinases. This increases the assembly of actin 
bundles, which stretch between focal adhesions forming stress fibers [38].  
Under tension, mature FA typically show retrograde movement, to the center 
of the cell. It is thought that this retrograde movement serves as a signal delivery system 
[39], locally passing information into the cytoplasm. The arrangement of molecules 
varies within the focal adhesion as well, with the center-distal area becoming the load 
bearing structure where molecules do not easily exchange. 
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Figure 6 Architecture of the focal adhesion 
Focal adhesions consist of several layers about 80-120nm in height and crossing the 
cell membrane. The lower most layer is made up of integrins that associate with the 
ECM. The cytoplasmic tails of the integrins link to the signaling layer which have FAK 
and paxillin. These structures are interspersed with proteins like talin and vinculin, 
which bind to actin forming the force transduction layer. The formation of stress fibers 
is regulated by alpha-actinin and formins in the actin regulatory layer.  (Adapted from 
[37]) 
  
The recruitment of vinculin is dependent upon tension and vinculin uses 
tension to stabilize the interaction between FAK and paxillin [40]. FRAP studies have 
shown that the recovery of paxillin and vinculin is slow in the force bearing area of the 
focal adhesion [41, 42].  
After maturation FA do not respond to further stress by increasing in size. This 
might be because of a switch of functions in the individual FA components, the type of 
proteins present at the FA and their phosphorylation states. Mature FA are then used as 
anchors to maintain cell shape, able to detect substrate properties across the length of 
the cell enabling integration of signals[43]. This can be used by the cell for aligning the 
cell, and its stress fibers, along an axis optimal for information collection especially on 
stiff or cyclically stretched substrates [44-46]. Signaling from the focal adhesions 
controls an array of cellular functions, like, cell survival, proliferation, migration and 
differentiation [46-50]. 
 Focal adhesions have a lifetime of about 10-20 min with the possibility of 
further maturing into fibrillar adhesions which have the capability to modify the ECM 
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[51, 52]. For a migrating cell, disassembly of focal adhesions at the rear of the cell 
precludes forward movement[53]. Mature and stable FAs require actin bundling by 
myosin IIA and myosin IIB activity. The stable adhesions have no Rac signaling 
resulting in a local GEF depletion. The lack of GEFs is interpreted as the rear of the 
cell and those focal adhesions disassemble [54].  
FA disassembly is governed by both molecular and mechanical factors[55]. 
Disassembly takes place at the leading edge and at the rear of the cell during movement 
and retraction. At the molecular level, the FAK-Src signaling pathway controls the 
phosphorylation of Myosin light chain kinase (MLCK) by MAP kinase which increases 
contractility. Integrin receptors are released under high tension as a result of increased 
contractility. Further, FAK’s phosphorylation of paxillin [56], as well as Calpain2’s 
cutting action on talin, FAK and paxillin leads to focal adhesion dissociation [57] 
(Figure 7). Microtubules are also known to cause destabilization of focal adhesions 
leading to dissociation [58-60]  
 
Figure 7 Focal adhesion formation and signaling  
Focal adhesion signaling and turnover is related to its position in the cell. Nascent 
adhesions form at the leading edge of the cell where with the help of Rac activity actin 
polymerization they mature into focal complexes. Further action by myosin II leads to 
the recruitment of molecules like zyxin via Rho ROCK activity leading to the formation 
of a mature adhesion. Focal adhesion disassembly takes place at the rear of the cell due 
to increased tension, depletion of local GEFs and Calpain activity.(Adapted from [61]) 
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The force felt by individual proteins has differentially affects their exchange 
rates [62, 63]. Further, the type of substrate the cell experiences determines the focal 
adhesion turnover rates. Soft substrates have focal adhesions that frequently turnover 
while stiffer substrates allow for focal adhesions that are much more stable and 
elongated. The substrate properties experienced by the cell can be varied under 
experimental conditions by using substrates of varying stiffness or by altering the 
geometry experienced by the cells using techniques such as micro-pillars and micro-
contact printing.  
 
 
Figure 8 Stages of focal adhesion maturation 
The composition of focal adhesions changes with focal adhesion maturation in a 
tension dependent manner. Paxillin, talin and integrins are the earliest of FA members. 
Focal complexes have FAK, alpha actinin which are joined by vinculin, zyxin, VASP 
and others upon formation of focal adhesion maturation. Besides composition the 
phosphorylation states of individual proteins also varies leading to differential 
signaling depending on the maturation state of the adhesions. (Adapted from [64]) 
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1.3 Nuclear transport 
The complexity of information gathered by focal adhesions increases with their 
maturation. Many proteins like, FAK, Src, and Rho family kinases  send signals to the 
nucleus via direct translocation or via signaling cascades. [65]. Cellular systems use a 
limited number of molecules to form functional modules for specific functions. Nuclear 
transport of molecules from the FA to the nucleus, represent a signaling and regulation 
component, taking cues directly from the ECM and affecting the cellular behavior.  
The process of nuclear transport requires the working together of multiple 
players. These include the nuclear pore complex, carriers of proteins, importins, 
proteins with NLS [66]. The cargo into and out of the nucleus is of RNA, proteins and 
their respective carriers. Some proteins have a nuclear localization sequence which 
makes them good candidates for ferrying other proteins into the nucleus. The nuclear 
export sequence allows the export of proteins from the nucleus. LIM domain proteins 
are dependent on Crm1/exportin1 for their nuclear export. When cells are treated with 
LMB there is an enrichment of these proteins in the nucleus.  
The LIM domain proteins have been shown to localize to both the cytoplasm 
and the nucleus[67] and recognized as key components in the regulatory mechanism of 
the cell[68]. The LIM domain proteins Trip6 and LPP localize to telomeres and could 
play a role in senescence[69]. Along the same lines, Ajuba has been implicated in DNA 
damage response mechanism and cell cycle progression[70]. 
1.3.1 Zyxin 
Zyxin has been shown to shuttle between the focal adhesions and the nucleus [71], and 
is dependent upon Crm1 for its nuclear export [72]. In vascular cells, Zyxin’s nuclear 
transport depends on stretch followed by protein kinase G mediated phosphorylation 
of serine 142. [73]. In cardiomyocytes and vascular smooth muscle cells zyxin acts as 
a transcription factor for thrombomodulin and calponin and the chemokines 
interleukin-8 (IL-8, monocyte chemoattractant protein 1 and vascular cell adhesion 
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molecule–1 (VCAM-1). In endothelial cells transcription of hairy/enhancer-of-split 
related with YRPW motif 1 (Hey-1) protein is also controlled by zyxin. [74-76]. Zyxin 
contributes to UV-induced apoptosis[77]. Zyxin also responds to epidermal growth 
factor and requires Akt activation for nuclear transport [78]. 
1.3.2 Trip6 
Trip6 also shows Crm1 dependent nuclear export[79]. Localizes to telomeres and 
possible role in senescence[69]. Besides telomeres Trip6 goes to promoters of genes 
and activates expression in conjunction with AP-1 or NF-κB [80, 81]. 
1.3.3 Ajuba 
Although mostly cytosolic in mouse 3T3 cells, the nuclear transport of Ajuba in P19 
embryonal cells inhibition of growth and endodermal differentiation. [82]. Ajuba has 
also been implicated in DNA damage response and cell cycle progression[70]. 
1.3.4 Hic5 
Hic5 is a close relative of paxillin has been reported to bind to DNA[83]. Hic-5 has an 
oxidation sensitive NES and controls the expression of c-Fos [84]. Interactions with 
focal adhesion kinase (FAK) and protein tyrosine phosphatase PEST (PTP-PEST) work 
in concert with oxidation to inhibit nuclear transport [85]. It is likely that Hic-5 uses 
the LIM4 domain to forms an oligomer with PINCH and ILK making a nuclear 
shuttling complex, which is not observed with paxillin [86].  On a higher scale, Hic-5 
controls anchorage dependence of cell growth by circumventing the nuclear 
localization of cyclin D1 in detached cells[87].  
1.3.5 LPP 
LPP has 41% sequence identity with zyxin, it is known to bind VASP and its nuclear 
export is inhibited by LMB [88]. Identified in lipomas and functions as a proto-
oncogene[89]. Though normally located at focal adhesions, it is often permanently 
localized to the nucleus in some tumors [90].  
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1.4 Effect of geometry on mechanotransduction 
 Focal adhesion maturation is dependent on acto-myosin activity. Actin flows 
in a centripetal manner all over the cell, focal complexes require these low levels of 
actin flow for maturation and even a small level of cytochalasin D treatment stops the 
formation of focal complexes without disturbing the overall cytoskeleton [2, 25, 91]. 
Actin behavior can be controlled by changing the cell geometry, affecting focal 
adhesion assembly pattern and Rac activity[92]. Controlling the actin organization 
affects myosin activity[93] and allows the control of focal adhesion formation[94]. 
Cells can detect edges [95] and focal adhesions usually form at the corners of 
micro-printed geometries where they experience high tension[96]. A circular shape 
simulates a spread cell with centripetally moving circumferential stress fibers. A 
triangular shape provides straight edges along which stress fibers and strong adhesions 
at the corners[97](Figure 9). 
 
Figure 9 Effect of geometry on cell organization 
Cells exposed to different geometries show altered behavior. A small adhesion area 
causes low contractility. A circular shape has increases spreading but lower 
contractility as compared to triangular shapes. Cells show branched actin meshwork all 
over the edges on circular patterns but only at corners on triangular patterns. FA are 
formed preferentially at corners on geometries that have corners. (Adapted from [97]) 
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In un-patterned cells, adhesions in the center of the cell show no response to 
force. Adhesion size is correlated with force at the cell edge but not towards the 
interior[98]. Binding kinetics are affected by the mechanical forces felt at the focal 
adhesions. In the case of zyxin, higher tension contributes to a slower recovery of zyxin, 
and suggests the presence of a catch-bond mechanism at FAs[99]. Thus the geometries 
also control the binding kinetics of focal adhesion proteins and focal adhesion 
maturation. This allows for changes in cell spreading and migration accompanied by 
local changes in the cytoskeleton and ultimately affects gene expression[2]. Cyclic 
stretching causes Zyxin-mediated changes in gene expression in smooth muscle 
cells.[100]. Large scale changes are effected by limiting the cells to certain geometries.  
 Geometry of a cell controls the cell’s survival, proliferation, differentiation and 
polarity[101]. The axis of cell division can also be controlled by geometry[102]. 
Capillary cells undergo apoptosis on smaller geometries accompanied by a drop in 
DNA synthesis [103]. Geometry influences cell functioning and fate, RhoA signaling, 
combined with geometry, has been shown to control stem cell differentiation into either 
osteoblasts or adipocytes depending on adherence [104, 105]. Primary fibroblasts 
undergo apoptosis on stressed gels[106]. Large populations of cells are also affected 
by geometry, for example stem cells follow differentiation routes based on the macro 
geometry of the population[107].  
In some ways geometries emulate the stiffness of substrates. Cells remain 
round on soft substrates and elongate on stiffer ones[45] this is similar to exposing cells 
to different geometries. Besides FA, mechanosensitive channels are put under tension 
they change the local cell permeability to calcium leading to oscillations in calcium 
levels. This process might be mechanosensitive as the authors also reported an 
increased oscillation on stiffer substrates[108]. Paxillin responds to geometry by 
affecting Rac activity. In paxillin -/- cells exposed to square patterns, Rac activity is 
diffuse while in the WT cells show Rac activity only at the corners[109].  
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Changes in forces also cause local changes at focal adhesions. Relaxation of 
force by Y-27632 treatment affects various FA proteins differently[63]. Therefore, 
changing the cell geometries to coerce cells into different actin organization affects the 
force felt at adhesions and would modify the exchange rates of focal adhesion proteins. 
The focal adhesion proteins FAK, vinculin and paxillin are of interest to the present 
study and all show force dependent behavior.  
 
1.5 Paxillin family of proteins 
Paxillin is one of the earliest proteins recruited to the nascent adhesions. There 
are three members of the Paxillin family, namely, Paxillin, Hic-5, Leupaxin [6]. While 
Hic-5 is expressed with paxillin and found in many cell types, Leupaxin is expressed 
only in leukocytes[11]. The Paxillin family members possess a set of N-terminal 
leucine rich LD motifs having the LDXLLXXL consensus sequence [11, 110]. The 
paxillin family of proteins are also LIM (Lin11, Isl-1, and Mec-3) domain proteins 
displaying the characteristic C-terminal zinc-finger LIM domains (Figure 10).  
Although the double-zinc-finger LIM domain structure is similar to DNA 
binding transcription factors they most likely do not bind directly to DNA. The ability 
to influence transcription has so far only been shown at LD motifs. The Hic-5 LIM 
domains have been shown to bind DNA, however the experiments were done only in 
vitro [111, 112].  
 
Figure 10 Paxillin Family   
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The paxillin family consists of proteins containing 4 C-terminal LIM domain and N-
terminal LD motifs with the consensus sequence (LDXLLXXL). The LD motifs are 
usually employed for signaling while the LIM domains have focal adhesion targeting 
properties. Paxillin has 5 LD domains and several phosphorylation sites which control 
its function as a scaffold protein. Paxillin has two other beta and gamma forms which 
are only expressed in some tissues. There is also a minor delta form which does not 
include the LD1 motif and is expressed in epithelial cells. Hic-5 and Leupaxin are 
paxillin paralogs of which Hic-5 is expressed with paxillin while Leupaxin is expressed 
only in leukocytes. (Adapted from [11]) 
 
Several of the LIM domain family, like zyxin, Trip6, Hic-5, and paxillin 
proteins translocate to the nucleus where they interact with transcription factors. Of 
these, zyxin is very well characterized and known to affect transcription directly [113, 
114]. Zyxin has a well-defined nuclear export sequence (NES) which is lacking in 
paxillin. However, a nuclear localization sequence (NLS) has not been shown in either 
zyxin or paxillin. This suggests that both these proteins are carried to the nucleus by 
some other factor. Zyxin has been shown to translocate to the nucleus as a response to 
stretch[115]. However no such direct mechanism has been reported for paxillin.  
 
1.5.1 Paxillin 
The name paxillin is derived from the Latin word for peg, paxillus, which fits 
well in its early proposed function of connecting actin filaments to cell adhesions [11, 
116]. Paxillin was first discovered in 1989 as a 68-kDa focal adhesion protein which, 
upon v-Src expression, showed an increase in tyrosine phosphorylation [117]. In 1994 
paxillin was shown to be a 559-amino acid protein by a λgt11 expression screening 
[118]. Subsequently, it was identified as a direct binding partner of the vinculin tail 
domain [116].  
Today, paxillin is known to be a scaffold protein connecting several signaling 
and regulatory molecules to control adhesion dynamics, cell migration and several 
downstream pathways [6, 11]. Paxillin consists of two sets of important domains; the 
C-terminal consists of four LIM domains while the N-terminal half has five LD 
domains. LIM (Lin11, Isl-1, Mec-3) domains are double-zinc finger domains  [119, 
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120] which are present in all eukaryotes but not in prokaryotes[67]. Paxillin forms 
protein-protein interactions via its LD motifs while the LIM domains are important for 
focal adhesion targeting[121]. Besides focal adhesions, paxillin also associates with 
hormones receptors and cell-cell adhesion components [122, 123], adding further 
complexity to its interactions and behavior.  
Paxillin knockout is embryonic lethal and the function of paxillin is not 
compensated for by its relatives Hic-5 and leupaxin. Besides cell survival paxillin has 
been indicated in inflammation[124], prostate cancer[125], lung cancer[126], via its 
interaction and to be important to the cell invasion process[127]. Paxillin is also very 
important for cervical cancer due to its interaction with the E6 protein from the 
pappiloma virus[128, 129] as it blocks paxillin’s interaction with vinculin and 
FAK[130]. This interaction has even been shown to be important for shear stress 
dependent cell survival[131]. 
 
 
Figure 11 Paxillin structure and major interactions 
Paxillin consists of 5 LD motifs and 4 LIM domains. The LD motifs are important for 
several protein-protein interactions and are surrounded by several phosphorylation 
sites. These interactions control downstream pathways affecting numerous cell 
functions. (Modified from [11]) 
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1.5.2 Paxillin LD Motifs 
LD motifs are short α-helical amphipathic with a degenerate consensus sequence, 
LDXLLXXL. The same LD motif can be recognized by LD motif-binding domains 
(LDBDs)[132]. LD motifs possess the ability to bind to FAK and vinculin, which was 
also how they were first discovered[121]. 
 
 Paxillin LD motif 
Proteins LD1 LD2 LD3 LD4 LD5 
FAK      
PYK2      
CCM3      
Vinculin      
GIT1      
α-Parvin      
β-Parvin      
PV E6 (BE6 and 16E6)      
Bcl-2      
PABP1      
CRM1      
Table 1 Paxillin’s LD Motifs and interacting partners 
Paxillin uses its LD4 sites for several protein-protein interactions. These interactions 
control FA dynamics, nuclear export and are also involved in disease.(Adapted from 
[132]) 
 
1.5.3 Recognition of LD motifs 
Many different ligand domains recognize LD domains with micromolar range 
affinities[132]. Although the LD domains remain similar the ligands are diverse in their 
structure. In most cases LD domains are identified via a region similar to FAK’s FAT 
(focal adhesion targeting) domain known as the FAT-homology domain (FAH). 
Although FAH domains are known usually to bind LD domains this is not always the 
case[133].  
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FAH domains 
FAK FAT domain: FAK is important at the FA for assembly, disassembly and signaling 
functions via its scaffolding and kinase activities. FAK is found in other cellular 
compartments, including the nucleus, for kinase-independent functions [134, 135]. 
FAK has an N-terminal FERM domain (4.1/ezrin/radixin/moesin), a central tyrosine 
kinase domain which is joined to a C-terminal FAT domain via a 220aa flexible linker. 
FAK needs the interaction between FAT and paxillin’s LD motifs for its recruitment 
to the FA although talin based FA recruitment has also been reported [136, 137].  
The FAT is a ~150 amino acid long region and is present at the C-terminal of 
FAK. It is made up of 4 antiparallel alpha-helix bundles that have a highly conserved 
hydrophobic region[10]. Modeling studies suggest that FAT unravels in force 
dependent steps and that this unraveling affects the hydrophobic surface used to bind 
paxillin. Moreover, the binding of paxillin to FAT stabilizes the structure and more 
force is required to unravel FAT[138]. 
Paxillin enhances FAK’s dimerization and intra-domain interactions thereby 
promoting FAK’s kinase dependent functions[139]. Crystal structures and NMR 
analysis have shown interactions between the LD2 and LD4 motifs and the FAT 
domain of FAK. The binding of LD motifs to FAT displaces FAK’s N-terminal domain 
and stabilizes the four-helix structure of FAT [140-142]. Affinity of FAK-FAT to the 
LD4 motif might be reduced by phosphorylation of Ser272 and Ser274 of human 
paxillin (Ser273 and Ser275 in chicken paxillin)[143] . Binding between paxillin and 
FAT is force dependent and equibiaxial strain has been shown to cause stronger binding 
between FAT and paxillin[144]. FAT binding is also dependent on two other paxillin 
sites, D146 and D268 [145, 146]. 
PYK2 FAT domain: PYK2 is a close homolog of FAK having a 60% sequence identity 
but differing in their regulation [147, 148]. Though PYK2 does bind to the positions of 
LD4 as FAK it is not strongly localized to FAs[149]. PYK2 has an N-terminal 
extension which doesn’t allow proper interaction and seems to cause the LD motif to 
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become flexible which might play a role in ligand selection [132]. Although there is a 
report of PYK2 affecting Hic-5 and paxillin’s nuclear transport but molecular details 
are not discussed [150]. 
1.4.4 Paxillin Phosphorylation sites 
Over 50 possible phosphorylation sites on paxillin have been identified by 
mass spectrometry[151]; adhesion stimuli, growth factors and others activate many 
different kinases that target paxillin. Some of these include FAK[145], Abl[152], 
PAK(p21-activated kinase) [153],  ERK (extracellular-signal-regulated kinase)[154, 
155], RACK1(receptor for activated C kinase) [156], CDK5 (cyclin-dependent kinase 
5)[157], p38 MAPK (p38 mitogenactivated protein kinase)[158, 159], JNK (Jun N-
terminal kinase)[158, 160]. 
Focal adhesion maturation is affected by paxillin phosphorylation. The Y31 
and Y118 sites are particularly important and phosphorylated paxillin shows increased 
lamellipodia protrusions, while non-phosphorylated paxillin is important for FA 
maturation. Cytosolic FAK-paxillin association increases with the phospho-mimetic 
form of paxillin at the Y31 and Y118 sites [56].  The recruitment of vinculin to FA is 
also controlled by the FAK mediated Y31 and Y118 phosphorylation of paxillin[8]. 
Paxillin interacts with androgen receptor and EGF-receptor and regulates cell 
proliferation by enhancing the activity of FAK and Erk[161]. 
Affinity of FAK-FAT to the LD4 motif is reduced by phosphorylation of 
Ser272 and Ser274 of human paxillin (Ser273 and Ser275 in chicken paxillin)[143]. 
The S272 and S274 sites in the LD4 domain on human paxillin have been shown to be 
important in FAK binding and has been shown important for paxillin’s nuclear export. 
Paxillin phosphorylation at the S273 and S275 (S272 and S274 in human paxillin) site 
via the p21-activated kinase (PAK) increases paxillin-GIT1 binding which is important 
for focal adhesion turnover leading to increased cell migration and protrusion[153, 
162]. A S2D mutation in these sites reduces GIT1 binding[162]. 
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1.4 Important paxillin interactions 
Paxillin has many interactions that modify its behavior, recruitment and localization. 
Here we discuss the proteins that are implicated in controlling paxillin’s nuclear 
translocation.  
1.4.1 FAK  
Focal adhesion kinase (FAK) is one of the most well studied kinases at the focal 
adhesion. Paxillin’s FAK mediated phosphorylation at the Y31 and Y118 sites is 
important for the control of Rac1 signaling by the binding of Crk to paxillin.  Paxillin 
Y31-Y118 important for focal complexes formation via FAK-paxillin complex 
formation. Phosphomimetic paxillin increases focal complexes formation while 
phospho-inhibition causes reduction in FAK-paxillin interaction and focal adhesions 
elongate but don’t turn over[163]. The complete removal of FAK causes stabilization 
of focal adhesions due to increased contractility[164]. 
 
 
Figure 12 Domain arrangement of FAK 
FAK has a central kinase domain that is controlled by the FERM domain. The FERM 
domain also contains the NLS and NES to transport in and out of the nucleus. Paxillin 
binding is mediated by the FAT domain. (Modified from [135]) 
 
FAK itself is affected by contractility and gets phosphorylated at Y397 [165]. 
One of the things that makes FAK interesting is its nuclear shuttling from the FA to 
nucleus[166]. It has been suggested that the focal adhesion targeting (FAT) domain 
mediated FAK-paxillin binding might carry paxillin to the nucleus[1] as FAK 
possesses an NLS (which paxillin lacks) in its FERM domain.  
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1.4.2 Vinculin  
Vinculin is another major FA protein linking the actin cytoskeleton. Vinculin associates 
with several cytoskeletal and signaling proteins and its tail binds to paxillin. The 
vinculin tail forms a five helix bundle and is similar to FAH[167]. Mutational analysis 
has shown that Vinculin binds to a single LD motif at a time although it can bind LD 
motifs 1,2, and 4[168]. Although the exact binding site is yet to be determined the 
similarity to FAH suggests a similar mode of binding[169]. Vinculin is implicated in 
the use of force as a signal for the recruitment and dissociation of focal adhesion 
proteins [170]. 
1.4.3 GIT1 
The GIT (G-protein-couples receptor kinase interacting) proteins interact with paxillin 
to link the Rho guanine-nucleotide-exchange-factors, PIX (p21-interacting exchange 
factor), and their binding partners, the p21-activated protein kinases to FAs [171, 172]. 
A C-terminal four-helix FAH is the most likely way that GIT proteins bind to LD motifs 
2 and 4[162, 173]. Although it’s likely that GIT1 binds only one LD domain at a time, 
multiple interactions with paxillin may be possible due to GIT’s dimerization and/or 
binding to PIX and FAK [174, 175], thus, providing a much more nuanced signaling 
base at the FAs. Paxillin phosphorylation at the S273 and S275 (derived from chicken, 
equivalent toS272 and S274 in human paxillin) site via the p21-activated kinase (PAK) 
increases paxillin-GIT1 binding which is important for focal adhesion turnover leading 
to increased cell migration and protrusion[153, 162]. A S2D mutation in these sites 
reduces GIT1 binding[162].  
1.4.4 PABP1  
Poly-A binding protein (PABP) has a high affinity for paxillin (~10nM) and is 
postulated to transfers mRNA from the nucleus to the leading edge of the cell. The 
atomic structure of the paxillin-PABP complex has not been worked out but the PABP1 
RNA recognition motif and LD1 are most likely to be involved [176, 177]. 
25 
 
 
1.4.5 CRM1  
CRM1, also known as exportin1, is an adaptor protein involved in the export of over a 
100 proteins by the recognition of the NES (Nuclear Export Sequence). Although the 
exact binding between CRM1 and paxillin has not been worked out, CRM1 contains 
HEAT repeats which provide a similar LD motif binding site as FAHs [132, 178]. 
Leptomycin B blocks the nuclear export of CRM1 dependent proteins by covalent 
modification at a cysteine residue[179].  
 
 
Figure 13 Overview of important paxillin interactions 
A. Paxillin undergoes fast exchange at immature FA as compared to mature FA. B. 
Immature FA show faster disassembly rates as compared to mature FA which are under 
force due to acto-myosin links. C. Paxillin has force dependent binding partners such 
as vinculin and FAK D. The exact signal or binding partner that controls paxillin’s 
nuclear translocation is unknown. E. In the nucleus, paxillin stimulates the transcription 
of H19, c-Fos and Cyclin D1 genes thus playing a part in cell proliferation. F. 
Leptomycin B (LMB) blocks the export of paxillin by binding with CRM1.  
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1.7 Aims and Objectives of study 
 
Paxillin is one of the earliest markers for focal adhesion and much is known 
about its function and regulation at the focal adhesions and recent research has shed 
some light on the nuclear function of paxillin. The exact mechanism of paxillin’s 
nuclear transport remains unclear. The aim of this study is to explore the physical and 
molecular mechanism that might control the nuclear transport of paxillin.  
 
Major objectives of study: 
 Explore the relation of traction force on paxillin’s nuclear transport 
 Explore the role of molecular players involved 
 Identify specific molecular sites that can affect paxillin’s nuclear transport 
 
In summary, we have found that the nuclear transport of paxillin is affected by 
geometry and possibly by the presence of FAT domain proteins. Geometry controls 
traction force which can in turn affect the focal adhesion turnover rate. Force affects 
the exchange of paxillin from the focal adhesions via the actions of FAK and vinculin. 
Knocking out either FAK or vinculin causes a large rise in nuclear paxillin, which is 
reversible via rescue. FAK and vinculin associate with paxillin using the FAT domain. 
We find that overexpressing FAT in cells causes a reduction of nuclear paxillin. The 
exchange of paxillin at focal adhesions is very low in the presence of FAT domains, as 
seen by FRAP studies.   
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2. Materials and Methods 
Cell Culture: 
RPTPα+/+ mouse embryonic fibroblasts [180]were generous gifts from Dr. Sap JM, 
NYU, New York, NY, USA. Cells were cultured in high glucose DMEM (+L-
glutamine, +Phenol Red, +Sodium Pyruvate) with 10%FBS and 1% Penicillin 
streptomycin. Cells were split at about 80% confluency. And 10% of the cells were 
seeded for cell line maintenance. We used TrypLE™ Express Enzyme (1X) (without 
phenol red) to trypsinize cells. Before conducting an experiment cells are trypsinised 
with TrypLE for 30s-2min. The trypsin is then neutralized with complete media and 
the cells are centrifuged at 1500rpm for 3 min and then re-suspended in complete media 
for 30min before seeding for experiment.  
2.1 Constructs and Point Mutations: 
YFP-paxillin construct was a kind gift from Bershadsky lab 
Y31EY118E Y31F were a kind gift from Geiger lab[56] 
The following constructs were created in-house: 
We generated several point mutations in house below listed are the primer sequences 
used: 
Hu-paxillin S272/S274D 
Hu paxillin S272/S274 D -Fwd 
GAC GAG CTG ATG GCT GAC CTG GAC GAT TTC 
Hu Paxillin S272/S274 D -Rev 
GAA ATC GTC CAG GTC AGC CAT CAG CTC GTC 
Hu Paxillin S272/S274 A -Fwd 
GAC GAG CTG ATG GCT GCG CTG GCG GAT TTC 
Hu Paxillin S272/S274 A -Rev 
GAA ATC CGC CAG CGC AGC CAT CAG CTC GTC 
 
FAK I936/998E  
Ms FAK I936E-Fwd 
CTA GTG AAG GCT GTC GAA GAG ATG TCC AGC 
Ms FAK I936E-Rev 
GCT GGA CAT CTC TTC GAC AGC CTT CAC TAG 
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Ms FAK I998E-Fwd 
GAC TTA GGC GAG CTC GAA AGC AAG ATG AAG 
Ms FAK I998E-Rev 
CTT CAT CTT GCT TTC GAG CTC GCC TAA GTC 
 
FAK Y925E 
Ms FAK Y925E- Fwd 
TCC AAT GAC AAG GTA GAG GAA AAT GTG ACA 
Ms FAK Y925E-Rev 
TGT CAC ATT TTC CTC TAC CTT GTC ATT GGA 
Ms FAK Y925F- Fwd 
TCC AAT GAC AAG GTA TTT GAA AAT GTG ACA 
Ms FAK Y925F-Rev 
TGT CAC ATT TTC AAA TAC CTT GTC ATT GGA 
 
Super FAK (K578E/K581E) 
mFAK K578E - F  
GAC AGT ACT TAC TAT GAA GCT TCC AAA GGA 
mFAK K578E -R 
TCC TTT GGA AGC TTC ATA GTA AGT ACT GTC 
Use template K578E and do mutation K581E 
mFAK K581E – F 
TAC TAT GAA GCT TCC GAA GGA AAA TTA CCT 
mFAK K581E- R 
AGG TAA TTT TCC TTC GGA AGC TTC ATA GTA 
 
2.2 Transient Transfection 
Transfection of DNA was carried out by electroporation using the Neon Transfection 
System from Life Technologies. 
General Protocol: 
1. Grow cells until 70-80% confluent in a T-25 tissue culture flask. 
2. After trypsinization neutralize with complete media then centrifuge at 
1500rpm for 3min 
3. Remove all possible media leaving just the cell pellet 
4. Resuspend cell pellet in about 12µl of  R (or T) buffer 
5. Add 1µg DNA to cells and mix gently. 
6. Electroporate using cell-appropriate settings. 
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7. After electroporation add cells to media and let them settle 
8. After about 2 h change media 
9. Perform experiment about 16hrs post transfection 
 
 
Cell type Voltage: Time: Pulse 
WT MEFs 1600V 10ms 1 
FAK-/- and  
Vin-/- 
1200V 30ms 1 
Table 2 Electroporation settings for transient transfection 
 
2.3 Micropatterning 
The micropatterning protocol was adapted from an earlier publication[181].Cells were 
seeded on circular or triangular patterns of 1600µm2. The micropatterns were created 
by stamping fibronectin (100µg/ml) with micropatterned PDMS substrates onto Ibidi 
brand imaging grade plastic bottom dishes. These were then passivated with pluronics 
to prevent cell attachment outside the fibronectin patterns. Detailed protocol below: 
PDMS micropatterns: 
1. Silicon molds were created using photo-lithography techniques 
2. The molds are washed with iso-propanol and dried with compressed air to 
remove debris from previous uses. 
3. These molds were coated with silane by evaporating the liquid with the silicon 
mound under vacuum. This coating prevents PDMS from forming bonds with 
the silicon molds.  
4. The PDMS is mixed with the curant in a 1:10 ratio and then degassed at 
<10mBar for 30min.  
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5. The degassed PDMS is then poured onto the silicon molds and then degassed 
again to remove all bubbles. 
6. The PDMS is then cured at 80ºC for 2hrs and allowed to cool prior to removal 
from molds. Note: PDMS shrinks over time affecting the dimensions of the 
desired patterns. For best results freshly molded PDMS is preferred. 
7. Using a sharp scalpel, taking care not to etch the silicon mound, the patterned 
PDMS is cut into smaller sections and peeled. The patterned side of the PDMS 
can be identified by the slight diffraction caused by the patterns. 
8. The micro-patterned PDMS is then plasma treated to make the surface 
hydrophilic. 
9. In a tissue-culture hood, 100µg/ml fibronectin solution is added on the 
patterned side and excess is dabbed from the edges with a tissue. 
10. The fibronectin is then allowed to dry until it covers just the top of the patterns. 
Different patterns dry in different ways and it is best to check the patterns under 
the microscope every minute taking care to cover the molds before removal 
from the hood. For faster drying the patterns may be left exposed to the laminar 
flow.  
11. Using sharp bent forceps fibronectin coated patterns are then inverted on to 
plastic bottom dishes without moving the pattern to prevent smudging. A slight 
pressure is applied evenly over the back of the stamp to ensure consistent 
printing.  
12. The dish is then inverted and the PDMS removed in a fast downward motion 
to prevent smudging. To ensure proper stamping the fibronectin may be mixed 
with a fluorescent dye and visualized under a microscope. If so desired, tagged 
fibronectin can be used in small concentrations allowing imaging of the pattern 
after washing with PBS and seeding cells. 
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13. At this point the cells can attach to the plastic or to the fibronectin patterns. To 
control the place of attachment the surface is passivated i.e. coated with PLL-
PEG (pluronics) solution for 30min. 
14. The dish is gently washed with PBS prior to seeding cells.  
 
2.4 Drug treatments 
Drugs were diluted in required solvent and control samples were treated with same 
volume of solvent. 
Drug Treatment Company 
Acrylamide 5mM 4h Sigma 
Actinomycin D 5µg/ml 12h Sigma 
Blebbistatin 25µM 1h Sigma 
Calpain inhibitor 1 &2 10µM 2h Sigma 
Calyculin A 100nM for 30min Sigma 
Cycloheximide 100µg/ml 12h Sigma 
Latrunculin A 400nM 1h Sigma 
Leptomycin B 
(LMB) 
150nM for 1h A.G. Scientific, Inc. 
San Diego 
Nocodazole 5µM 30min Sigma 
PLC inhibitor U-73122 1-2uM 30min Sigma 
PP2 25µM 1hr Sigma 
U0126 1.5hr Sigma 
Table 3 Drug treatment conditions and provider 
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2.5 Immunocytochemistry   
Reagents: 0.1% Triton X-100 (in PBS) (TX-100), 4%PFA, 0.5% tween (in PBS), PBS, 
NH4Cl, 5%BSA in PBS (Blocking buffer)  
Protocol: 
1. After experiment, wash sample with PBS 2 times and then  fix with 4% PFA 
for about 15min 
2. Wash with PBS 2 times, Wash with NH4Cl 2 times, wash with PBS 2 times 
3. Permeabilize cells with 0.5% tween 20 (~15min) (this works better for nuclear 
staining of paxillin compared to 0.2% Triton X-100) 
4. Wash with PBS 2 times and add blocking buffer for 1 hour 
5. Remove buffer and add diluted primary antibody 1 h, diluted in blocking buffer 
6. Wash gently with 0.1% TX-100 4 times then with PBS 2 times 
7. Add secondary antibody for 1 hour, diluted in blocking buffer 
8. Wash gently with 0.1% TX-100 4 times then with PBS 2 times 
Antibodies: 
Antibody Animal, company, (catalog number) 
Mouse (monoclonal) 
Anti-Human Paxillin 
Unconjugated 
AHO0492  Invitrogen 
 
Various Secondary goat anti-mouse 
Alexa Fluor antibodies 
Invitrogen 
Table 4 Antibody details 
 
 
2.6 Microscopy  
All imaging was done using the Perkin Elmer Spinning Disk microscope or 
DeltaVision fluorescence microscope. The spinning disk imaging used the UplanSApo 
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60x water immersion (1.20 NA, UPlanSApo 100x, Olympus, Center Valley, PA, USA), 
or 100x oil immersion (1.40 NA, UPlanSApo100x, Olympus, Center Valley, PA, USA) 
and cooled EMCCD camera (C9100.13, Hamamatsu Photonics, Hamamatsu, Japan). 
For the DeltaVision the 100x oil immersion lens (1.40 NA, UPlanSApo100x, Olympus, 
and Center Valley, PA, USA) with a cooled CCD camera (Photometrics CoolSNAP 
HQ2). An environmental chamber (37°C and 5% CO2) was attached to the microscope 
body for long-term time-lapse imaging.  The camera parameters and microscope 
settings were kept fixed, in order to cross-compare different cells.   
2.7 FRAP Analysis 
A simple MATLAB program was used to extract FRAP intensity values at 
bleach spots. Analysis method was derived using several sources [182, 183]. Briefly, 
the intensity data was background subtracted and normalized. Multiple curves were 
then normalized and averaged. Average normalized FRAP curves were fitted in 
Origin9.1 using the Levenberg Marquardt iteration for the following equation for 
diffusion uncoupled FRAP [182]: 
𝐼(𝑡) = 1 − 𝐴𝑒−𝑘1𝑜𝑓𝑓𝑡 − 𝐵𝑒−𝑘2𝑜𝑓𝑓𝑡 
The koff and immobile fraction values were derived from fitted curves. 
2.8 Statistics 
Statistics was performed with R programming environment. Data were 
expressed as standard errors of the mean (±SEM). Statistical significance was 
determined using Holm-corrected pairwise signiﬁcance testing (*p < 0.05; **p < 0.01; 
***p < 0.001). Each NTIR measurement is an average of more than 50 cells over 
multiple experiments.  
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2.7 Programming 
2.7.1 MATLAB Image analysis program: 
Since the major method of quantifying nuclear translocation was measuring 
the NTIR traditional methods from earlier studies were found unsatisfactory. Methods 
like measuring the intensity along a single-pixel wide line across the nucleus and 
cytoplasm in a z-projected image not only obfuscates the data but also exposes the data 
to user-bias. We felt that a more satisfactory method was using 3-D confocal image 
stacks to identify nucleus and whole cell and then measuring the intensities. To achieve 
this manually using an analysis program, like Imagej (or Fiji), to outline cells and nuclei 
and then measuring intensities would take about two minutes for each image. The 
average cell number in for a single experimental group is about 50 cells, each hyper-
stack contains about 10 slices of nuclei and cell channels. To process 500 images would 
then take about 1000mins or approximately 17 continuous hours for each group. I 
taught myself MATLAB image analysis to escape spending a prohibitively large 
amount of time for the analysis of a single experiment. Early programs were re-written 
over the course of this thesis and the program discussed below is the final version. 
The aim of this program was to cut down as much time as possible and further 
to limit the inputs from the user a minimum. Once the program reached it’s a refined 
version, the only thing that had to be changed in program was the file path to the image 
data. With the same theme of minimal effort in mind the normal practice of exporting 
the image data from the microscope-specific files (like .mvd2 for Perkin-Elmer 
Spinning Disk or .dv for DeltaVision) to .tiff images was completely removed by using 
the open-source Bio-formats for MATLAB toolbox, which at the time of writing was 
available here: 
 https://www.openmicroscopy.org/site/support/bio-formats5/users/matlab/  
However, the bio-formats system usually loads the entire file into the RAM, 
which is highly memory inefficient as multi-hyper-stack files like .mvd2 can easily 
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reach several gigabytes for a single dataset. To counter-act this, a slightly tweaked 
version of Bio-formats was written. This version allowed the access of individual 
hyper-stacks thus allowing the program to analyze a single cell at a time and running 
smoothly on a standard laptop. On an average the program takes about 40min to analyze 
an experimental set with 6 groups. When combined with the plotting program described 
later the time from raw data to a plotted result is about an hour. Although not fully 
exploited in this program, MATLAB supports the distribution of jobs onto multiple 
computers such as a computational cluster. Using those features along with a capable 
cluster would considerably speed up the program. As software changes all the time it 
is recommended that only concepts from the algorithm be used to write a more up-to-
date program as changes in later versions of MATLAB might cause misbehavior.  
For the sake of simplicity and understanding, most instances of nuclear 
analysis have been removed. Every action performed on the cell channel is performed 
on the nuclear channel. In the actual program actions on cell or nuclear channels are 
identified by suffixes or prefixes like xyz_cell or nuc_abc, simply replicating the same 
steps explained below and changing the suffixes or prefixes will add the nuclear 
analysis. The standard procedure used was to store a single experimental group in one 
.mvd2 file since those are interpreted as folders (i.e. directories) by windows. This 
allows the saving of the analyzed output in the same folder to maintain simplicity for 
later users.  
 
In order to know exactly what part of the image was detected as an object the 
program also saves images with threshold regions highlighted. This allows for the 
weeding out of occasional errors that slip through. 
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Figure 14 Sample output of image analysis 
Shown above is a z-stack of a cell thresholded in 3-D. Thresholding a 3-D stack as a 3 
dimensional matrix is advantageous over slice by slice as it allows for better 
identification of connected objects and out of focus intensities are not detected. Using 
a 3-D matrix instead of an array vastly improves processing speed. 
 
Appendix 6.1 explains a simplified program line by line. The green text 
preceded by the ‘%’ symbol is the comment explaining the function of the code. 
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2.7.2 R program for statistical analysis and automatic plotting of data 
The R Project for Statistical Computing is among the best software for the 
analysis of data and pleasing graphical output. Although MATLAB has plotting 
capabilities, the ggplot2 package in R gives much finer control over the cosmetic 
properties of a plot. Also, forcing a break in the data gathering and plotting allows for 
removal of false or badly thresholded cells. Programming in R is made much easier if 
the RStudio user interface is used.  
The following R program is designed to be used in conjunction with the excel 
sheet generated from previous MATLAB program. The program below is for the 
standard NTIR plot using the excel files as input and returning a horizontally plotted 
bar chart with error bars. All the values that need to be changed such as the axis labels, 
chart title, and target folder are located at the beginning of the program for easy access 
and to prevent accidental modification of the code.  
The average time taken for a chart to be generated is about 5sec depending on 
the size of data. Besides generating the plot the program also performs pair-wise 
comparisons with the Holm adjustment and outputs a p-value table with asterisks 
assigned to values that fall within the ranges: *p < 0.05,  **p < 0.01,  ***p < 0.001. As 
with all programs, extreme care should be taken check that the plotted values 
correspond to independent calculations methods for tests. The program has a line by 
line comments in appendix 6.2. A Sample p-value table output from the program is 
below 
  
38 
 
3. Results 
3.1 Endogenous Paxillin is trapped in the nucleus upon LMB 
treatment 
Leptomycin B (LMB) is used to inhibit nuclear export via the CRM1 (exportin) 
pathway. Although the exact mode of binding between CRM1 and paxillin is unknown 
the addition of LMB traps paxillin in the nuclei. Paxillin cycles through the nucleus 
and about 10% of total paxillin is present in the nucleus at a time. Using microscopy to 
track changes at low intensity levels is difficult; to overcome this problem we use LMB 
to enrich the nuclear paxillin. If experimental conditions cause an increase in the rate 
of transport to the nucleus then more paxillin is observed in the nucleus. In order to 
maintain a standard all cells are treated with 150nM of LMB for 1 hour. The nuclear to 
total intensity ratio (NTIR) of paxillin is used to quantify the fraction of paxillin that is 
present in the nucleus. Using the NTIR allows a standard comparison between cells 
irrespective of the paxillin expression levels.  
We show that both endogenous and YFP-paxillin show similar NTIR in MEF cells. In 
the case of transient transfections the NTIR does not depend upon expression levels. In 
further experiments, either endogenous staining or YFP-paxillin has been used 
depending upon ease of use in experimental conditions.  
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3.1.1 YFP-Paxillin translocates to the nucleus in about 60min  
WT mouse embryonic fibroblasts were transfected with YFP-paxillin for 24 
hours and nuclear translocation was recorded for 15min prior and 80 min post LMB 
(150nm) treatment. Paxillin is faintly noticeable in the nucleus at about 20 min and 
continues to accumulate until 60min after which the accumulation slightly slows down.  
As the NTIR at 60min was satisfactory, 60min LMB treatment was set as the standard 
for further experiments. 
A 
 
B 
 
Figure 15 Time scale for the nuclear localization of paxillin 
MEFs transfected with YFP-paxillin imaged for 90min. A. Montage of sample cell 
showing nuclear transport 15min prior to LMB addition till 60min post LMB addition. 
Scale bar, 20µm Movies were acquired using DeltaVision wide field microscope. B. 
Quantification of NTIR over 80min post LMB addition. LMB added at 0min. n=10cells 
error bars are SD 
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3.1.2 Endogenous paxillin also accumulates in the nucleus under LMB 
treatment  
 WT MEFs were treated with 150nM LMB for 1hr and fixed. Paxillin was then 
stained for using immunocytochemistry and the nucleus was stained with Hoechst. 
Analysis of confocal images shows that endogenous paxillin translocates to the nucleus 
as well as YFP-paxillin.  Endogenous paxillin and YFP-paxillin have been used 
interchangeably as per the requirements of the experiment. 
A 
 
B 
 
Figure 16 Nuclear transport of endogenous paxillin 
MEFs were plated on FN coated glass for 30min before 1h LMB treatment. Cells were 
fixed and immune-stained for confocal imaging. A. Maximum intensity projection of 
control and LMB treated cells. Top row is immune-stained paxillin, middle row is 
Hoechst stained nucleus and bottom row is pseudo-color overlay. Scale bar, 20µm B. 
Nuclear/Intensity Ratio (NTIR) quantification.   
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This result accuracy of the result obtained by image analysis was further checked 
using western blot. The nuclei of control and LMB treated cells were isolated and 
protein extraction was performed. The quantification of western blot data yielded a 
similar result as image analysis.   
 
 
Figure 17 Western blot and quantification of paxillin from isolated nuclei. MEFs were 
treated with LMB for 1 h before isolating nuclei. Lamin was used as loading control. 
Y-axis shows fold change between Control and LMB treated samples.  
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3.1.3 Nuclear translocation of YFP-paxillin is independent of expression 
levels 
 
To address the question of whether an overexpression of paxillin affects 
nuclear accumulation, we plotted the NTIR vs the total intensity of YFP-paxillin the 
cell. The total intensity gives the expression level of YFP-paxillin. As can be seen, 
there is no correlation between expression level and the NTIR. The mean NTIR for 
YFP-paxillin transfected cells is about 0.27 similar to that of endogenous paxillin. 
Although no direct relationship was observed, overexpression of any protein 
will affect cellular mechanisms. Therefore, in experiments cells not expressing a very 
high level of YFP-paxillin were imaged to minimize the effect of the overexpressed 
protein.  
 
 
Figure 18 Nuclear accumulation of paxillin independent of expression level 
NTIR is independent of expression levels, quantified by total intensity on y-axis 
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3.1.4 Cleaved paxillin is not responsible for nuclear signal  
Paxillin is cleaved by calpain and there was a possibility that the observed 
nuclear transport could be a result of a cleaved fragment of YFP-paxillin translocating 
to the nucleus. To test this, we applied calpain1 and calpain2 inhibitors to cells followed 
by LMB treatment. No significant change was observed in YFP-paxillin’s nuclear 
transport. Therefore the nuclear signal is not a result of cleaved paxillin.  
A 
 
B 
 
Figure 19 Paxillin's nuclear signal is not caused by calpain activity 
MEFs transfected with YFP-paxillin were treated with either Calpain 1 or Calpain 2 
inhibitor for 2 h prior to 1hr of LMB addition. A. Quantification B. Representative 
sample of cells Scale bar, 20µm 
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3.2 Matrix composition does not affect nuclear transport of 
paxillin: 
As the signaling at FAs varies depending on the type of integrin engaged we 
tested if changing the substrate affected paxillin’s nuclear transport. RPTP cells 
transfected with YFP-Paxillin were seeded on glass, fibronectin, laminin, and collagen. 
No significant differences were observed. This led us to conclude that paxillin’s nuclear 
transport does not depend upon the type of integrin that is engaged. 
A 
 
B 
 
Figure 20 Effect of substrate composition of paxillin’s nuclear transport 
MEFs transfected with YFP-paxillin were seeded on either glass, fibronectin, laminin 
or collagen substrates for 1 hour prior to LMB treatment. A. quantification B. 
representative samples. Scale bar, 10µm 
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3.3 Role of Acto-myosin network in paxillin’s nuclear 
transport 
Being a FA protein paxillin is involved in the force dependent FA maturation. 
We tested whether disruption of the acto-myosin network affected the nuclear transport 
of paxillin. We see that disruption of the actin network gives a slightly higher NTIR 
but no significant change is observed when contractility is disrupted by inhibiting 
myosin II.  
3.3.1 Actin disruption marginally increases nuclear transport of paxillin 
MEF cells transfected with YFP-paxillin were treated with Latrunculin A (LA) 
30min prior to LMB addition. Cells were fixed after one hour and imaged. LA treated 
cells had a disrupted appearance consistent with LA treatment and analysis revealed a 
higher NTIR.  
A 
 
B 
 
Figure 21 Effect of actin disruption on paxillin’s nuclear transport 
MEF cells were treated with Latrunculin A (LA) prior to LMB addition. A. 
Quantification B. Representative images, Scale bar, 20µm. 
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3.3.2 Myosin Inhibition does not significantly affect paxillin’s nuclear 
transport 
 WT MEFs transfected with YFP-paxillin were treated with Blebbistatin (BBi, 
25µM 1hr) inhibit contractility. A further 1h of BBi+LMB treatment followed before 
fixing. There was no significant change in the nuclear transport of paxillin.  
 
A 
 
B 
 
Figure 22 Effect of myosin inhibition on paxillin’s nuclear transport 
MEFs were treated with blebbistatin (BBi) for 1h prior to LMB addition. A. 
Quantification B. Representative images. Scale bar, 20µm.  
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3.3.3 Stimulating contractility by Calyculin A does not affect paxillin’s 
nuclear transport 
In order to see if an increase in contractility affected nuclear transport we used 
the strong Seer/Thr phosphatase inhibitor Calyculin A [184-186]. Cells were treated 
with 100 nM Calyculin A for 30 minutes prior to LMB addition. As with the 
blebbistatin treatment Calyculin A treatment also did not show a significant difference 
in paxillin’s nuclear transport.  
 
A 
 
B 
 
Figure 23 Stimulating actin contractility does not affect paxillin’s nuclear transport 
Cells transfected with YFP-paxillin were used to stimulate actin contractility with 
Calyculin A for 30min prior to LMB addition. A. Quantification B. Representative 
images. Scale bar, 20µm. 
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3.4 Geometry of cells affects nuclear transport of paxillin:  
The position and magnitude of the traction force generated by a cell depends 
upon the cell geometry. Traction force is exerted at corners of geometric shapes where 
strong adhesions are formed. Paxillin’s exchange at FA is dependent upon the traction 
force. We wondered if the cell shape might affect paxillin’s nuclear transport. We used 
micro-contact printing to force the cell into either a circular or triangular geometry. 
This arrangement allowed triangular cells to form strong adhesions at the vertices while 
the circular cells would not. We observe that YFP-paxillin in circular cells has greater 
NTIR as compared to triangular cells. This might be affected by the turnover rate of 
focal adhesions on the respective shapes.   
3.4.1 Nuclear transport greater in circles than triangles: 
Cells transfected with YFP-paxillin were placed on circular or triangular 
patterns and treated with 150nM LMB for one hour prior to fixing. The cells on circular 
patterns show a significant increase in the nuclear transport as compared to the 
triangular cells. Cell geometry affects the cytoskeleton, we next observed the 
differences in the actin organization in circular and triangular cells.  
A 
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B 
 
Figure 24 Effect of cell geometry on paxillin’s nuclear translocation 
Cells transfected with YFP-paxillin were plated on micro-contact printed fibronectin 
islands of either circular of triangular shape each of 1600µm2. A. Quantification B. 
Representative images. Scale bar, 10µm. 
 
 
3.4.2 FA turnover rates faster on circles: 
Concentric, transverse stress fibers appeared in cells on circular patterns, when 
observed with RFP-Lifeact. In contrast triangular cells showed strong, stable stress 
fibers along the edges. Quantification of the cell edge movement revealed that the edge 
of the circular cells moved about 1.5µm about the mean position while the triangle 
stayed relatively stationary. As was reported earlier cells form protrusions at the 
corners of geometric shapes. Thus measurements for triangles were done at the corners 
where maximum movement would be expected. The formation of focal complexes 
requires a low level of centripetal actin flow as circular cells show a constant centripetal 
movement of transverse actin we hypothesized that the FA turnover rate would be 
affected by cell geometry. 
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Figure 25 Effect of cell geometry on actin organization 
Cells transfected with Lifeact were seeded on patterns and live imaging was done for 
90min. Actin fibers at cell edges were tracked and movement from average position 
was measured 
 
Focal adhesion turnover was studied using cells transfected with YFP-paxillin 
on circular or triangular cells. Analysis of kymographs shows that the lifetime of FA 
on triangular cells is about twice that of circular cells. The average FA of a circular cell 
51 
 
turns over in about 30min compared to 70min for the triangular cell. As paxillin is a 
focal adhesion molecule we hypothesized that a change in focal adhesion turnover rates 
might also be affecting the nuclear transport of paxillin. 
 
A 
 
B 
 
Figure 26 Effect of cell geometry on focal adhesion turnover 
Cells transfected with YFP paxillin were seeded on patterns and live imaging was 
performed for 2hrs. Focal adhesion turnover was measured for each cell at 6 locations. 
For the triangle half of the points were on the corners and half on the edges. A. Cells 
with marked points of quantification on the left. Right side shows kymographs of 
selected areas. B. The turnover was measured and mean turnover is shown in the table.  
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3.5 Drug Treatments 
Since micropatterned cells show differences in FA turnover, we probed the role 
of various cytoskeletal and signaling elements by applying drugs and measuring the 
NTIR.  To simulate stabilization of FA we used Src and ERK inhibitors to stabilize 
focal adhesions. We also explored the role of Intermediate filaments and microtubules 
as both have been indicated to affect paxillin behavior.  
3.5.1 Src Kinase inhibitor PP2 
FA turnover is affected by Src based phosphorylation and inhibition of Src by 
PP2 reduces FA turnover[164]. We treated cells with 25µM of PP2 for 1hr with LMB. 
There was no difference observed in the NTIR of paxillin after Src inhibition.  
A 
 
B 
 
Figure 27 Src kinase inhibition has no effect of paxillin’s nuclear transport 
MEFs transfected with YFP-paxillin were treated with PP2 and LMB. A. 
Quantification B. Representative images. Scale bar, 20µm. 
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3.5.2 ERK inhibition:  ERK Inhibitor 
Similar to Src inhibition of ERK also reduces adhesion turnover [164]. Cells 
were treated with the ERK inhibitor, U1026 for 30min prior to 1h LMB treatment. As 
with Src, ERK inhibition showed no significant change in paxillin’s nuclear 
translocation.  
A 
 
B 
 
Figure 28 Effect of ERK inhibition on paxillin’s nuclear transport 
MEFs transfected with YFP-paxillin were treated with ERK inhibitor U1026 (ERK[i]) 
for 30min prior to LMB addition. A. Quantification B. Representative cells. Scale bar, 
20µm. 
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3.5.3 Intermediate filament disruption by Acrylamide  
Disruption of intermediate filaments reduces cytoskeletal tension independent 
of actin or microtubules [187]. Intermediate filaments can be disrupted by acrylamide 
treatment [188, 189]. We treated cells with 5mM of acrylamide for 4h before LMB 
addition. There was no significant effect on the reduction in NTIR of paxillin.   
 
A 
 
B 
 
Figure 29 Effect of intermediate filament disruption on paxillin’s nuclear transport 
MEFs transfected with YFP-paxillin were treated with acrylamide to disrupt 
intermediate filaments for 4h prior to LMB treatment. A. Quantification. B. 
Representative images. Scale bar, 10µm. 
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3.5.4 Nocodazole 
Paxillin is known to accumulate at the microtubule organizing center and focal 
adhesion disassembly takes place in a paxillin dependent manner due to microtubule 
targeting [190, 191]. We used 5µM of nocodazole (Noc) for 30min prior to LMB 
addition to disassemble microtubules [192, 193]. There was no difference in paxillin’s 
nuclear transport due to microtubule disruption.  
A 
 
B 
 
Figure 30 Effect of microtubule disruption on paxillin’s nuclear transport 
MEFs transfected with YFP-paxillin were treated with Nocodazole (Noc) prior to LMB 
treatment. A. Quantification B. Representative images. Scale bar, 20µm. 
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3.4.5 Effect of Cycloheximide & Actinomycin D 
Poly-A Binding protein (PABP-1) is known to depend upon paxillin for its 
export in some cell types [177, 194]. Treatment of cells with cycloheximide and 
actinomycin D causes localization of PABP to the nucleus [194]. To test if this had a 
major effect on paxillin’s nuclear transport we treated cells cycloheximide (CX) (100 
μg/ml 12h) and actinomycin D (Act D) (5μg/ml; 12 h) prior to LMB treatment. The 
LMB treated samples showed a slight increase in paxillin’s nuclear transport but there 
was no effect on the non-LMB samples indicating that PABP-1 has a minor effect on 
paxillin’s nuclear import.  
A 
 
B 
 
Figure 31 Stimulation of PABP nuclear transport on paxillin’s nuclear translocation 
MEFs transfected with YFP-paxillin were treated with only actinomycin D or with 
cycloheximide. LMB was added after 12h of treatment. A. Quantification B. 
representative images. Scale bar, 20µm. 
57 
 
3.7 Vinculin and FAK knockout 
 Vinculin enhances the association between FAK and paxillin when under 
force[8]. Since we observe that paxillin on triangular cells has lower nuclear 
translocation we hypothesized that association with vinculin or FAK would be involved 
in paxillin’s nuclear transport. Since paxillin lacks a nuclear transport signal it has been 
suggested that FAK forms a complex with paxillin which then translocates to the 
nucleus[1]. FAK shows nuclear translocation and we used FAK knockout (FAK-/-) 
MEFs to test if FAK role in paxillin’s nuclear transport. We also investigated whether 
vinculin presence affect’s paxillin’s nuclear transport by using vinculin knockout (Vin-
/-) MEFs. Paxillin has increased nuclear translocation in both Vin-/- and FAK-/- cells. 
This is reversible by rescue of vinculin and FAK respectively. Vinculin is known to be 
recruited to focal adhesions by a FAK dependent phosphorylation of paxillin at the Y31 
and Y118 sites. We tested if the phosphor-mimetic and non-phosphorylatable Y31 and 
Y118 paxillin mutants showed any difference in nuclear localization. There was no 
difference in paxillin’s localization in WT, Vin-/- of FAK -/- cells. However, the 
overexpression of FAK caused a reduction in the nuclear transport of paxillin and we 
pursued this further. 
 FAK was inhibited by a drug, giving no difference in paxillin’s transport. We 
used superFAK to see if there was further retardation of paxillin’s nuclear transport but 
levels came down to similar levels as WT FAK. The FAK Y925 mutant is known to 
stabilize focal adhesions so we tested this as well, but there was no difference observed. 
Finally, we tried the FAK I936/I998 mutant which inhibits FAK-paxillin association 
due to the mutation in the focal adhesion targeting domain (FAT). Adding this construct 
to the cells did not retard paxillin’s nuclear translocation leading us to believe that the 
FAK-paxillin binding might act as a signal to prevent paxillin’s nuclear translocation.  
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3.7.1 Vinculin or FAK Knockout increases nuclear transport of paxillin: 
Vinculin knockout (Vin -/-) MEFs were transfected with YFP-paxillin and 
nuclear translocation was observed after LMB treatment. The NTIR for Vin-/- cells 
treated with LMB WT MEFs cells treated with LMB. A similar result is observed with 
endogenous paxillin. This increase was reversible, as shown when Vin-/- cells were 
rescued with Vinculin-mCherry.  
A 
 
B 
 
Figure 32 Vinculin or FAK knockout increases nuclear paxillin 
MEFs, Vin-/- and FAK-/- cells were transfected with YFP-paxillin and seeded for 
30min prior to LMB addition. A. Quantification B. Representative images. Scale bar, 
20µm. 
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3.7.2 Vinculin Rescue 
Rescuing the knockout of vinculin with mCherry-Vinculin reverses the effect 
and paxillin translocation is lowered. This indicates that vinculin plays a role in 
inhibiting paxillin’s nuclear transport.  
A 
 
B 
 
Figure 33 
Vin-/- cells were transfected with YFP-paxillin and mCherry Vinculin. Cells were 
seeded for 30 min prior to LMB addition. A. Quantification B. Representative images. 
Scale bar, 20µm. 
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3.7.3 FAK rescue 
FAK -/- cells upon rescue with mCherry-FAK also show a lowered nuclear 
signal. This indicates that the presence of FAK in the cell is important for retention of 
paxillin in the cytoplasmic compartment.  
 
A 
 
B 
 
Figure 34 FAK rescue reduces nuclear paxillin in FAK-/- cells 
FAK-/- cells were transfected with YFP-paxillin and mCherry-FAK. Cells were seeded 
for 30min prior to LMB addition. A. Quantification B. Representative images. Scale 
bar, 20µm.  
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3.7.4 FAK -/- with blebbistatin treatment 
The morphology of FAK-/- cells is different from WT MEFs due to an increase 
in contractility and reduced FA turnover[164]. To address the concern that the increase 
in NTIR is not a result of the morphology we treated FAK-/- transfected with YFP-
paxillin with blebbistatin for 30min before adding LMB. Blebbistatin causes the cells 
to relax and spread out more. We see that the addition of BBi has no effect on paxillin’s 
nuclear transport. Leading us to conclude that it is the absence of FAK that is primarily 
responsible for the increased nuclear translocation of paxillin.  
A 
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Figure 35 Relaxation of FAK-/- cells by BBi does not affect paxillin’s nuclear 
translocation 
FAK-/- cells transfected with YFP-paxillin were treated with Blebbistatin (BBi) for 
30min prior to LMB addition. A. Quantification B. Representative images. Scale bar, 
20µm.  
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3.7.5 Mutations in paxillin’s phosphorylation sites do not affect nuclear 
transport 
 Paxillin has several sites whose phosphorylation is controlled by its association 
with various proteins. Given that paxillin shows differential transport on geometries it 
is a possibility that a change in binding partners signaled by FA maturity could play a 
role in paxillin’s nuclear transport. To check if a simple phosphorylation switch 
controlled paxillin’s nuclear transport we tested the Y118 and Y31 sites, which are 
phosphorylated by FAK, as well as S272 and S274 mutants which have been implicated 
in paxillin’s nuclear export and important for GIT1 binding.  
 We found that there isn’t any change in the nuclear transport of mutant paxillin 
compared to WT paxillin. This led us to conclude that in WT MEFs paxillin 
phosphorylation does not affect the nuclear transport of paxillin.  
 
3.4.1 Y31 and Y118 mutant 
Vinculin recruitment to FA is dependent upon FAK mediated phosphorylation 
of paxillin at the Y31 and Y118 sites[8], moreover there is increased cytosolic FAK-
paxillin interaction with the phosphomimetic paxillin-Y31E-Y118E mutant [56]. 
Paxillin is phosphorylated at Y31 and Y118 by FAK. We used the phosphomimetic 
(Y2E) and the non-phosphorylatable (Y2F) double mutants of paxillin to study if this 
had an effect on nuclear transport. There was no significant difference in the NTIR 
between WT paxillin, the Y2E or Y2F mutants. Adhesion turnover is reduced by Y2F 
mutants[164]. 
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Figure 36 Paxillin Y31 and Y118 sites have role in nuclear transport 
MEFs were transfected with YFP-WT-Paxillin or the Y31 & Y118 Y2E and Y2F 
mutants. Cells were seeded for 30min prior to LMB addition. A. Quantification. B. 
Representative images. Scale bar, 10µm. 
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To test whether the Y2E and Y2F mutants of paxillin showed altered behavior 
in an environment lacking vinculin or FAK, we transfect Vin-/- and FAK-/- cells with 
the Y2E and Y2F mutants of paxillin. However neither Vin-/- nor FAK-/- cells 
displayed any significant difference in the localization of paxillin mutants. 
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Figure 37 Paxillin’s Y31 & Y118 sites do not affect nuclear transport in Vin-/- or FAK-
/- cells 
FAK-/- and Vin-/- cells were transfected with YFP-WT-Paxillin or the S272/274 
mutants. Cells were seeded for 30min prior to LMB addition. A. Quantification for 
Vin-/- cells B. Representative images. Scale bar, 10µm. C. Quantification for FAK-/- 
cells D. representative images. Scale bar, 10µm. 
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S272 and S274 mutants 
Affinity of FAK-FAT to the LD4 motif might be reduced by phosphorylation 
of Ser272 and Ser274 of human paxillin (Ser273 and Ser275 in chicken paxillin)[143]. 
The S272 and S274 sites in the LD4 domain on human paxillin have been shown to be 
important in FAK binding and has been shown important for paxillin’s nuclear export.  
Paxillin phosphorylation at the S273 and S275 (S272 and S274 in human 
paxillin) site via the p21-activated kinase (PAK) increases paxillin-GIT1 binding which 
is important for focal adhesion turnover leading to increased cell migration and 
protrusion[153, 162]. A S2D mutation in these sites reduces GIT1 binding[162]. Here 
we transfected cells with a double mutant of paxillin at the S272 and S274 sites as used 
before. There was no change in NTIR between WT YFP-paxillin, YFP-paxillin S272A, 
S274A, YFP-paxillin S272D, S274D. 
 
 
A 
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Figure 38 Paxillin’s S272/S274 sites not important for nuclear transport 
MEFs were transfected with YFP-WT-Paxillin or the S272/274 mutants. Cells were 
seeded for 30min prior to LMB addition. A. Quantification. B. Representative images. 
Scale bar, 20µm. 
 
  
 
As the affinity of FAK to S272 and S274 had not been tested in a background 
lacking FAK we tested whether the paxillin 272/S274 S2A and S2D mutants behave 
differently in FAK-/- cells compared to WT cells, we transfected FAK-/- cells with 
WT-YFP-paxillin and the S272/S274 S2A and S2D mutants. Like the WT cells there 
was no difference observed in the NTIR of paxillin mutants in FAK-/- cells. The S2D 
mutation which is reported to reduce GIT1 binding does not show increased nuclear 
activity, although the S2A mutation shows a slight decrease. 
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Figure 39 Paxillin’s nuclear transport unaffected by S272/274 mutation in FAK-/- cells 
FAK-/- cells were transfected with YFP-WT-Paxillin or the S272/274 mutants. Cells 
were seeded for 30min prior to LMB addition. A. Quantification. B. Representative 
images. Scale bar, 20µm. 
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3.7.6 Super FAK  
A dominant active form of FAK, known as ‘SuperFAK’ shows increased 
phosphorylation of FAK substrates. To test whether increased FAK activity would 
affect paxillin’s nuclear translocation we co-transfected mCherry-SuperFAK with 
YFP-paxillin overnight before LMB treatment. We did not see a change in paxillin’s 
nuclear translocation that was significantly different from the addition of WT-FAK. 
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Figure 40 Paxillin’s nuclear transport not affected by SuperFAK 
MEFs were transfected with YFP-paxillin and mCherry FAK or SuperFAK. Cells were 
seeded for 30min prior to LMB addition. A. Quantification B. Representative images. 
Scale bar, 20µm. 
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3.7.7 FAK Y925 mutant 
Increased interaction between paxillin and the nonphosphorylatable FAK-
Y925F mutant have been described to cause increased FA stabilization [195]. 
Phosphorylation of the Y925 site increases FAK-Grb2 association[196]. Thus using a 
nonphosphorylatable FAK reduces competition and increases the likelihood of FAK-
paxillin interactions. To test if this would change the nuclear paxillin levels we 
transfected WT-MEFs with YFP-paxillin along with either WT-FAK-mCherry or 
FAK-Y925-mCherry. There was a similar reduction in the nuclear paxillin levels in the 
presence of FAK-Y925 as with WT FAK, indicating that this interaction doesn’t 
significantly affect paxillin’s nuclear transport.  
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Figure 41 FAKY925 has no effect on paxillin’s nuclear translocation 
MEFs were transfected with YFP-Paxillin and mCherry-FAK or FAKY925F. Cells 
were seeded for 30min prior to LMB treatment. A. Quantification B. Representative 
images. Scale bar, 20µm. 
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3.7.8 FAK I936/I998 mutant 
The association between FAK and paxillin is highly reduced if the I936/I998 
residues of FAK are mutated [127]. The association of FAK and paxillin primarily 
takes place at the LD4 domain via the I936/I998 residues. To see if the association via 
this domain could affect paxillin’s nuclear transport we transfected WT MEFs with WT 
FAK-mCherry and the FAK I936E/I998E-mCherry point mutant. We observe that cells 
expressing WT FAK have a reduced nuclear translocation of paxillin while cells 
expressing the FAK I936/I998 mutant show normal levels of nuclear transport. This 
experiment was repeated in FAK-/- cells with the same results. This leads us to 
conclude that the I936/I998 based FAK-paxillin association impedes paxillin’s nuclear 
transport.  
A 
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Figure 42 FAK I936/I998 based association important for paxillin’s nuclear transport 
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MEFs were transfected with YFP-paxillin and either mCherry-FAK or mCherry FAK 
I936 mutant. Cells were seeded for 30min prior to LMB addition. A. Quantification. B. 
Representative images. Scale bar, 20µm. 
 
3.8 FAT domains inhibit exchange of paxillin at FA retard 
nuclear translocation  
3.8.1 FAT domains inhibit nuclear translocation 
Addition of FAK reduces the transport of paxillin. We hypothesized that only 
the FAT domain, which binds to paxillin, would be sufficient to slow the transport of 
paxillin to the nucleus. Binding between paxillin and FAT is force dependent and 
equibiaxial strain has been shown to cause stronger binding between FAT and 
paxillin[144]. We expressed mCherry-FAT for 8 hours before the LMB treatment. The 
NTIR of endogenous paxillin for FAT expressing cells treated with LMB was reduced 
compared to the cells not expressing FAT.  
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Figure 43 FAT overexpression retards paxillin’s nuclear transport 
MEFs transfected with m-Cherry-FAT were immunostained for paxillin. A. 
Quantification B. Representative images. Scale bar, 20µm. 
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3.8.2 Paxillin recovery at focal adhesions retarded by the presence of FAT 
domains 
Next, we also tested the effect of FAT on paxillin dynamics in WT cells, Vin-
/-, FAK-/- and cells transfected with mCherry-FAT. While both Vin-/- and FAK-/- cells 
showed slow, but full recovery the cells expressing FAT had a highly stable fraction of 
paxillin at the focal adhesions. This indicates that paxillin’s nuclear translocation might 
be inhibited by its binding to FAT domains at focal adhesions.  
The following equation was used to fit the FRAP data: 
𝑰(𝒕) = 𝟏 − 𝑨𝒆−𝒌𝟏𝒐𝒇𝒇𝒕 −𝑩𝒆−𝒌𝟐𝒐𝒇𝒇𝒕 
The derived The K2off of control cells matches well with previously measured koff 
values of paxillin[184].  
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Figure 44 Paxillin FRAP at focal adhesions 
FRAP at focal adhesions was performed on cells transfected with YFP-paxillin. A. 
Representative images of cells. Arrows in leftmost column indicate bleach spot. Panels 
on left are zoomed in FA before during and 150sec after photobleaching. Inset shows 
equally scaled intensity based look-up table colored bleached FA. B, C, D, E. Top 
panels show residual plots of fitted FRAP data on the bottom panel F. Plot of immobile 
fractions derived from FRAP plots. G. Table shows values of fitted data and graph 
shows k1off and k2off values.  
77 
 
3.9 Summary of Results 
 Nuclear translocation is exhibited both by endogenous as well as YFP-paxillin, 
translocation is blocked by LMB and takes about 60min for a strong signal 
 Translocation is not dependent upon paxillin expression level  
 The type of integrin that is engaged does not play a role 
 Nuclear paxillin is not a calpain-cleaved form  
 Actin disruption leads to slightly increased nuclear paxillin 
 Cells on circular patterns have higher nuclear paxillin as compared to triangular 
cells 
 This might be due to the actin organization of triangular cells and the stable 
adhesions  
 FAK-/- and Vin-/- cells show increased nuclear paxillin. This can be reversed by 
rescue 
 The Y31, Y118, S272/S274 sites on paxillin do not affect its nuclear import.  
 Expression of FAK, SuperFAK, and FAKY925F mutant all affect paxillin’s 
nuclear transport to similar levels.  
 FAK I936/998 mutant does not affect paxillin’s nuclear transport 
 FAT domains inhibit nuclear transport of paxillin 
 FAT domains also prevent paxillin exchange at focal adhesions 
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Chapter 4: Discussion 
Having well defined functions at focal adhesions, Paxillin’s presence in the 
nucleus is of great interest. Nuclear translocation provides a direct link from the 
mechanosensing focal adhesions to the transcriptional control machinery. As paxillin 
is present throughout the life of a focal adhesion the mechanism controlling its nuclear 
transport would hint at the cellular processes that are affected. Other LIM domain 
proteins such as zyxin are well studied and their transport mechanisms known. 
Paxillin’s nuclear translocation has been difficult to explain. Besides not having a 
defined nuclear transport signal, paxillin’s numerous partners add to the complexity, 
making it a difficult problem to unravel {Deakin, 2008 #881}. We show that paxillin’s 
transport to the nucleus is affected by focal adhesion turnover and association with the 
LD4 binding region of FAT domains.  
Focal adhesion maturation is a process that starts when nascent adhesions 
experience force. During maturation, several molecules such as the FAT/FAH 
containing proteins like FAK and vinculin are recruited along with complexes such as 
the GIT-PIX-PAK complex. This maturation process not only increases the number of 
paxillin interactions but also cellular processes that can be influenced. We used micro-
patterning to show that focal adhesion turnover can be induced by confining cells to 
particular geometries which also affects paxillin’s nuclear transport.  
Combining the geometric constraints with biochemical experiments gives us a 
better understanding of the events that govern paxillin’s nuclear transport. We show 
that paxillin’s nuclear transport is increased in the absence of FAK and vinculin. FAK 
targets paxillin using the FAT domain vinculin and α/β-catenin have  homologous 
domains which are also used for paxillin binding [10]. Each of these proteins use 
paxillin as a scaffold to sense and react to the signals from the focal adhesion. Paxillin 
affects FAK activity and the association with catenins changes Rac/Cdc42 activity 
causing changes in cell-cell junctions and tissue integrity [197, 198]. Thus, controlling 
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the nuclear transport of paxillin has implications at the single cell as well as the tissue 
level.  
We propose that paxillin needs to cycle through the focal adhesion 
compartment before nuclear transport can take place. However, stable and mature focal 
adhesions would provide an excess of binding partners to paxillin, retarding its nuclear 
transport. Overall, paxillin probably acts as a long term signal for cell attachment and 
proliferation with lowered nuclear transport for better attached, quiescent cells.  
 
4.1 Dependence on actin organization 
Focal adhesion maturation requires traction forces to recruit proteins and form 
complexes. Depending on focal adhesion maturity paxillin exists in different 
phosphorylation states. This state depends on force and differences are observed even 
within a single adhesion. Areas of higher force in the adhesion have lower exchange 
rates for paxillin while the peripheral regions have a quicker exchange with 
cytoplasmic pools.  
When we record the nuclear translocation of paxillin after disrupting actin with 
Latrunculin A we see an increase in the nuclear translocation. However, this change is 
not as large as when compared to the FAK-/- and Vin-/- cells. Conversely increasing 
actin contractility with Calyculin A does not affect paxillin’s nuclear transport.  It is 
possible that the actin disruption has an indirect effect on paxillin’s nuclear transport 
as a result of a tension based change in vinculin interactions[199].  
Actin disruption slightly increased the nuclear transport which brought up the 
question of whether paxillin’s nuclear transport depended upon the F-actin/G-actin 
ratio like in the case of MRTF-A[24]. Although, paxillin has been reported to localize 
on stress fibers[200] the lack of a strong signal indicates that paxillin would not follow 
an MRTF-A type of nuclear transport. It is possible that the small increase in paxillin’s 
nuclear transport could result from the formation and dissociation of focal complexes. 
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An increased focal adhesion dissociation rate would allow for more paxillin molecules 
to pass through the compartment. However disruption of the acto-myosin network by 
drugs is usually very harsh and can cause unintended effects. We used micro-contact 
printing to simulate more natural environments and to coax cells into certain adhesion 
states. 
 
4.2 Effect of geometry  
 The modulation of cell contractility using micro-contact printed protein islands 
is well studied [95, 181, 201, 202]. The geometry of a cell is very important in the 
sensing of the cell environment. Not only does the geometry affect how much traction 
force the cell generates but also large scale responses like differentiation and migration 
are controlled by geometry. Cells are somehow able to sense the physical properties of 
the island upon which they are seeded. Cells form adhesions at corners of shapes and 
stress fibers along straight edges. Cells can also extend themselves over non adhesive 
areas to form stress fiber bridges between distant adhesions[97]. 
 In this study we forced a circular or triangular geometry on the cells. We did 
not use a pattern with an adhesion free edge as it would have exposed cells to unequal 
adhesive areas although elicited greater contractility. To maintain constant conditions, 
we used 1600µm2 patterns. We observed stabilization of adhesions in triangles, while 
circular cells displayed much more rapid turnover. Concomitantly circular cells showed 
a faster rate of nuclear transport of paxillin as compared to triangular cells.  
 Triangular cells show strong stress fibers along the edges which lead to greater 
force and stable adhesions. Stable adhesions indicate a higher focal adhesion maturity 
and a lower molecular exchange rate at the points of force [41, 42]. In contrast circular 
cells show few mature focal adhesions and the majority form and dissociate along the 
edges. These two states of behavior could indicate that paxillin travels through focal 
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adhesion compartments more often on circular cells. Such behavior would not allow 
the association of paxillin with molecules found in stronger adhesions.   
Without using harsh drug treatments, we were able to modulate the 
contractility in a cell causing a change in focal adhesion formation. We speculated that 
the increased nuclear translocation of paxillin is a result of increased focal adhesion 
formation-dissociation cycles. In order to probe what molecular events might underlie 
this seemingly force dependent behavior of paxillin, we probed molecular partners that 
have been shown to have force dependent associations. 
 
4.3 Vinculin and FAK absence causes increased nuclear 
transport 
Paxillin has major interactions with FAK and Vinculin. Vinculin is known to 
stabilize FAK and paxillin interactions in a force dependent manner[8]. As we saw with 
the geometry that a drop in strong stress fibers caused an increase in nuclear paxillin, 
we wondered if the absence of major paxillin phosphorylation partners would affect 
nuclear transport. To test this we used FAK-/- and Vinculin-/- mouse embryonic 
fibroblasts. In both cases we observed that there was a drastic increase in nuclear 
paxillin. This was despite the fact that FAK-/- cells are highly contractile and have very 
strong focal adhesions.  
In order to test if this was reversible we rescued the knockout cells with 
mCherry FAK and mCherry-Vinculin. Both rescue cases showed a reduction in 
paxillin’s nuclear transport. A concern was that the FAK-/- cells are a smaller than 
normal cells and that this could lead to aberrant measurement of the nuclear/total 
intensity ratio. In order to relax the cells we treated them with mild blebbistatin. The 
cells relaxed and were larger and there was no change in paxillin’s nuclear presence.  
As FAK can also control FA turnover we tested if the non-phosphorylatable 
FAK-Y925F mutant would cause a change in the paxillin’s nuclear transport. Cell 
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migration is reduced and FA stabilization is seen in cells expressing FAK-Y925F [195]. 
This mimics the triangular pattern and could possibly reduce nuclear paxillin. To test 
this, cells were transfected with FAK-Y925F and WT FAK. Both, WT FAK and 
FAKY925F populations showed a marked decrease in nuclear paxillin. However, 
compared to WT FAK expressing cells, we did not observe the expected decrease in 
FAK Y925F expressing cells.  
 In order to see if increased FAK kinase activity would affect paxillin’s nuclear 
transport we employed the constitutively active ‘SuperFAK’ mutant [203]. Expression 
of SuperFAK did have a small but significant decrease in the nuclear transport of 
paxillin. This hinted that FAK mediated phosphorylation of paxillin could control 
paxillin’s nuclear transport. 
 
4.4 Phosphorylation of paxillin’s binding sites do not affect 
nuclear import 
Paxillin gets phosphorylated by FAK at focal adhesions upon FA maturation. 
Since we saw that a difference in focal adhesion turnover on geometries might be 
responsible for paxillin’s nuclear transport, we wanted to check if paxillin 
phosphorylation played a role in the transport. Paxillin’s Y31 and Y118 sites are targets 
for FAK mediated phosphorylation [204, 205]. There is also an increase in FAK-
paxillin association due to the phosphorylation of Y31 and Y118 sites[56].  
In order to test if the Y31 and Y118 sites play an important role in paxillin’s 
nuclear transport we used phosphor-mimetic(Y2E) or unphosphorylatable (Y2F) 
double point mutants at the Y31 and Y118 sites[56]. While the Y2E mutant showed no 
difference in nuclear transport, the Y2F mutant showed a small decrease in nuclear 
localization. The non-phosphorylated form of paxillin has been implicated in the 
formation of fibrillar adhesions[56]. This could mimic the conditions induced by 
83 
 
triangular patterns but block other interactions thus not giving a large effect in terms of 
nuclear transport.  
One of the other major interactions with paxillin via the FAT homology 
domain is by GIT1[162]. This interaction is mediated by the S272 & S274 sites on 
paxillin. The S272 site lies in the LD4 domain of paxillin and has been shown to be 
important for nuclear export. Mutation of these sites also reduces GIT1 but not FAK 
interactions[1]. If this parallel interaction with GIT1 also contributed to paxillin’s 
nuclear cycling then mutating the S272 and S274 sites would shed light on this process. 
However, compared to WT paxillin, double mutations, S2A and S2D, at the S272 and 
S274 sites did not elicit a significant change in nuclear accumulation.  
Having important interactions with FAK, it has always been thought that 
paxillin’s Y118 and Y31 phosphorylation sites would be of important for its nuclear 
transport. However, our results show that neither Y31/Y118 nor the S273/S274 sites 
have any bearing on the nuclear import of paxillin. It is possible that the decrease in 
nuclear paxillin observed in cells expressing SuperFAK could have been due to the 
exposed binding regions and not due to the phosphorylation activity of FAK. 
 
4.5 FAK I936/I998 mutation abrogates FAK mediated 
cytoplasmic retention of paxillin 
 FAK targeting to focal adhesions occurs via the FAT domain. The FAT domain 
is a 4 helix bundle having hydrophobic sites that bind to paxillin. This domain 
associates directly with paxillin and this interaction is important for the control of 
multiple downstream pathways. Point mutations at I936 and I998, which lie in the FAT 
domain, reduce FAK-paxillin binding by disrupting the LD4 binding domain of FAT 
[10, 127]. When we overexpress WT FAK in cells there is a reduction in paxillin’s 
nuclear transport. The same reduction is observed when we transfect either SuperFAK 
or the Y925 point mutant. However overexpression of the I936/I998 mutant does not 
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cause such a reduction leading us to conclude that the FAT domain is important for 
paxillin’s cytoplasmic retention.  
4.6 FAT domain binding reduces paxillin’s nuclear 
transport 
FAT and FAT-homology domains are used by various proteins to target 
paxillin. The LD2 and LD4 motifs of paxillin are particularly important for the 
association of paxillin with the FAT domain [110, 140]. Interestingly, several papers 
have referred to these same sites and highlighted their potential as a nuclear import 
signal, though there has not been any concrete evidence of their role. In this study, the 
addition of excess FAT to the system drastically lowers the nuclear transport of 
paxillin. Overexpression of FAT also blocks the recovery of paxillin at focal adhesions. 
FRAP studies with FAK-/- and Vin-/- cells show a slower recovery of paxillin but seem 
to have the same immobile fractions as WT cells. In cells transfected with FAT the 
recovery is much slower and have a large immobile fraction.  As FAT blocks the entry 
of paxillin into FAs and causes a lowered nuclear transport, it is plausible that paxillin 
needs to travel through the FA compartment prior to nuclear transport.  
Binding of FAT domains is also dependent upon stress which has been shown 
to increase the binding of FAT. In case of triangles, it is plausible that an increase in 
traction force at the cell corners causes an increase in the binding of paxillin to FAT 
domain containing proteins. This association is then likely to prevent paxillin from 
passing through the focal adhesion when a cell is well-attached. This stabilization 
would in turn reduce the number of paxillin molecules going to the nucleus acting as a 
signal for well-attached cells.  
Cells expressing FAT show reduced FAK phosphorylation FA localization. 
FAT expression reduces cell  migration  and primes cells for apoptosis by the activation 
of Caspase-3 [206]. Paxillin associates with ERK1 and ELK1 mediating cyclin D-1 
expression, via c-fos, thus controlling cell proliferation [125]. Cell motility is promoted 
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by Cyclin D-1 by inhibiting ROCK signaling[207]. It is possible that the 
overexpression of FAT blocks the nuclear transport of paxillin, reducing Cyclin D1 
expression, which in turn would block cell migration and thus, priming cells for 
apoptosis. 
 
Figure 45 Overview of results 
 
4.7 Proposed Model 
Based on the findings we propose that the nuclear translocation of paxillin 
requires its movement through the focal adhesions where interaction with FAT domain 
containing proteins via the LD4 domain determines nuclear transport. There is likely 
to be two populations of paxillin, one that always shows a nuclear transport phenotype 
and the other that doesn’t. A change in this nuclear fraction of paxillin could serve as 
a signal. We observed that cell geometry controls FA turnover and affects paxillin’s 
nuclear transport. However, this effect is not on a fast timescale, so nuclear paxillin 
likely acts as a long term signal of cell adhesion. Where, stronger FAs leads to lower 
nuclear paxillin. Paxillin controls cell proliferation by inducing transcription of cyclin 
D1 and the H19 gene [1, 125]. Thus an increase in cell motility causing increased FA 
turnover would also induce proliferation by the presence of nuclear paxillin.  
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Figure 46 Proposed model for paxillin transport and effects 
 
As we don’t observe an all or none type of nuclear signal we suggest that there 
might be multiple pathways controlling paxillin’s nuclear transport. Indeed, pathways 
controlled by androgen and EGF have already been reported to affect the expression of 
cFos and cyclin-D1 leading to proliferation of prostate cancer cells[125]. Multiple 
pathways might contribute to paxillin’s nuclear transport as there exists possible 
competition for paxillin binding between FAK, GIT1, βPIX, PABP, androgen receptor 
and vinculin. 
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4.8 Future Directions 
In this study, we have been able to reveal a small part of a complex story and 
many of the players involved in the process are yet to be discovered. A search for a 
focal adhesion dependent protein that carries paxillin to the nucleus is required. 
Moreover the traditional phosphorylation sites deemed important for its activity or 
those implicated in its nuclear transport have not shown any effect on paxillin’s nuclear 
transport. Identifying sites on paxillin that control its transport into the nucleus is 
crucial. 
Other sites on paxillin like D146 and D268 which affect FAK binding [145] 
should also be explored for their role. It is also a possibility that βPIX, (PAK-interacting 
exchange factor) carry paxillin to the nucleus. Nuclear transport is also exhibited by 
beta-PIX [208] and it binds to paxillin at the LD4 motif[171]. PIX is part of the GIT-
PIX-PAK complex. Larger, mature focal adhesions have reduced PIX localization [35, 
209]. This could imply that paxillin needs to go through nascent focal adhesions in 
order to bind PIX before nuclear transport. Presence of excess FAT domains, either 
artificially or due to FA maturation, could tilt the balance by competing for PIX binding 
thereby reducing nuclear paxillin.  
LIM domain proteins are emerging as important sensors of mechanical forces. 
A better understanding of how these proteins carry mechanical signals would provide 
better insights into the many mechanotransduction pathways in a cell.  A wider screen 
with the techniques used in this study would reveal more proteins whose nuclear 
translocation depends on traction forces generated by the cell.  
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6. Appendix 
6.1 MATLAB program 
%% pax_analyse_4 
%% Clear and clc clear MATLAB memory and command window this is good 
practice 
clear 
clc 
%% Setup this section of code is to set various initial values 
cell_chanl=1; % tells the program what channel is the cell channel 
  
cell_2d_area_thresh=10000; %used later to specify in pixels the minumum 
size of a 2-d object in this case a z-projected cell 
cell_3d_area_thresh= 30000;% same as above for 3-d objects 
  
root_root='Y:\Data\experiment\';% this is the path to the outer folder 
where data from several experimental groups is stored 
fold_list=dir(root_root);%this uses the dir function to get a list all 
the directories in the root_root path 
for fold_count=3:size(fold_list,1) %a for loop is then used to iterate 
over each directory in root_root 
    % Note: fold_count starts from '3' because windows systems designate 
    % '.' and '..' as the first two folders. Historically these were 
used 
    % to access parent folders and hence need to be skipped over 
    %% 
     
    root=[root_root fold_list(fold_count).name '\']; %the path to 
individual directories is automatically generated 
    %using the folder names stored in fold_list 
    img_write_path=[root 'results_' date '\']; %this designates the 
name for the folder where the results are to be saved 
    % the 'date' function returns the system date thus saving the date 
of 
    % analysis. 
    mkdir(img_write_path);%creates the folder to save files 
    file_list=dir([root '*.mvd2']); %gets a list of files ending with 
'.mvd2' 
    file_path=[root, file_list.name]; % above list is used to generate 
file path to the .mvd2 file 
     
    num_series=bfimgprop_aneesh(file_path); % this is a modified 
version of the Bio-formats bfimgprop 
    %that fetches the number of hyper-stacks in the file 
     
    all_obj_count=0; %the object count here counts the number of objects 
and needs to be initialsed to zero for later use 
    for img_count=1:num_series %uses the num_series to iterate through 
all the series in a multi-stack file 
        disp(file_path) 
        data = bfopen_aneesh(file_path,img_count); %custom version of 
Bio-formats bfopen uses num_series to return only specific series of 
data 
        
test_tot_chanl=str2num(data{1}{1,2}(find(data{1}{1,2}=='/',1,'last')+1
)); %gets total number of channels in imported image from metadata 
         
        if test_tot_chanl>=nuc_chanl && test_tot_chanl>=cell_chanl % 
program aborts if the total channels is less than the number set for 
cell and nuclear channels 
             
            %below code strips out cell channel normalises the data 
between 
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            %0 and 1 which is then smoothened. the orig_cell is used to 
            %make actual measurements. while cell_stack and 
smooth_stack 
            %are used to generate thresholds. The smoothening aids in 
            %getting a better signal. 
            orig_cell_stack=chanl_get(data,file_path,cell_chanl); 
            cell_stack=mat2gray(chanl_get(data,file_path,cell_chanl)); 
            
smooth_cell=smooth3(smooth3(cell_stack,'gaussian'),'gaussian'); 
             
            sum_cell=sum(cell_stack,3); 
            sum_smooth_cell=sum(smooth_cell,3); 
            
re_smooth_cell=reshape(smooth_cell,[],size(smooth_cell,2)*size(smooth_
cell,3)); 
             
            h = fspecial('gaussian', [3 3],0.5); 
            sum_smooth_cell=filter2(h, sum_smooth_cell); 
             
            bs_sum_smooth_cell=sum_smooth_cell-imopen(sum_smooth_cell, 
strel('disk',250)); 
            %graythresh is used for determining thresholds using Otsu's 
            %method 
            
bw_sum_cell=bs_sum_smooth_cell>graythresh(bs_sum_smooth_cell); 
            %holes in thresholded image are filled 
            se2=strel('disk',1); 
            bw_sum_cell=imclose(bw_sum_cell,se2); 
            bw_sum_cell=imdilate(bw_sum_cell,se2); 
            %now the properties of the indentified objects are stored. 
This 
            %allows for multiple objects to be detected in the same 
image 
            
bw_re_prop=regionprops(bw_sum_cell,'Area','BoundingBox','PixelIdxList'
,'PixelList'); 
             
            if ~isempty(bw_re_prop)%does not proceed unless some 
objects are detected 
                %all objects greater than the 2d-area threshold are 
                %identified and their indices stored in obj_idx 
                obj_idx=find([bw_re_prop.Area]>cell_2d_area_thresh); 
                %obj_count serves as counter and to reference objects 
above 
                %threshold and iterate over those 
                for obj_count=1:size(obj_idx,2) 
                    all_obj_count=all_obj_count+1; %object count is 
stored so as to be able to correlate stored data 
                    %with detected objects 
                    bb=bw_re_prop(obj_idx(obj_count)).BoundingBox; 
                    
pix_list=bw_re_prop(obj_idx(obj_count)).PixelIdxList; 
                    %initialize required variables 
                    [tmp cmc cc 
]=deal(zeros(size(cell_stack,1),size(cell_stack,2))); 
                    %in order to not process entire image a smaller part 
of the 
                    %image is cropped out and processed, cutting down 
uneeded data and speeding up the process 
                    %Because imcrop() does not work in 3-dimensions we 
are 
                    %forced to use a for loop to iterate over the stack 
in 
                    %order to obtain cropped stacks idetinfied by the 
                    %'crop_'prefix 
                    for count=1:size(smooth_cell,3) 
                        tmp=smooth_cell(:,:,count); 
                        cmc(pix_list)=tmp(pix_list); 
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                        crop_smo_cell(:,:,count)=imcrop(cmc,bb); 
                         
                        tmp=cell_stack(:,:,count); 
                        cc(pix_list)=tmp(pix_list); 
                        crop_cell(:,:,count)=imcrop(cc,bb); 
                    end                    
%% a 3d thresholded image is now generated from cropped stack and used 
further 
                    cell_thresh_fac=graythresh(crop_cell); 
                    cell_bw=crop_cell>cell_thresh_fac; 
                     
%fill holes                    
cell_bw=bwareaopen(imfill(imdilate(cell_bw,se2),'holes'),cell_3d_area_
thresh); 
% make new cell_bw which includes both cell and nuclear 
% pixels 
                    cell_bw=cell_bw|nuc_bw; 
%get properties of objects 
                    prop_cell_bw=regionprops(cell_bw,'Area', 
'PixelIdxList'); 
                    %proceed only if some objects are detected 
                    %iterate over objects greater than the 3d threshold 
                    % value 
                    if 
(sum([prop_cell_bw.Area]>cell_3d_area_thresh)&&sum([prop_nuc_bw.Area]>
nuc_3d_area_thresh)) 
                        %identifies those objects larder than the 
                        %3d-threshold 
                        
cell_pix_list=prop_cell_bw([prop_cell_bw.Area]>cell_3d_area_thresh).Pi
xelIdxList; 
%sometimes multiple nuclei are present in the same 
%cropped area the below for loop identifies those 
%nuclei with most pixels inside the cell-pixels 
for count=1:size(prop_nuc_bw,1) 
                            
nuc_pix_list=prop_nuc_bw(count).PixelIdxList; 
nuc_s=size(nuc_pix_list,1); 
cell_s=size(cell_pix_list,1); 
                            
member_pix=sum(ismember(nuc_pix_list,cell_pix_list)); 
                            % 
all(sum(ismember(nuc_pix_list,cell_pix_list))) 
                            
rat_member(count)=member_pix/size(nuc_pix_list,1); 
                        end 
%once the nucleus that is most inside the cell is 
%identified only those pixel indices are used for 
%further processing 
                        [~,in_cell_nuc_pix]=max(rat_member); 
                        
nuc_pix_list=prop_nuc_bw(in_cell_nuc_pix).PixelIdxList; 
                         
%Once the appropriate cell and nuclei have been 
%identified the pixels indices are used on the 
%cropped original cell image stack to measure intensity 
                        cell_area=max([prop_cell_bw.Area]); 
                        cell_int=sum(crop_orig_cell(cell_pix_list)); 
                         
%% an output image of original and thresholded cell and nuclei is saved 
%in order to enable easy screening of data for errors and 
                        %false detections 
                        [c bw_c ]=deal(zeros(size(cell_bw))); 
                        bw_c(cell_pix_list)=cell_bw(cell_pix_list); 
                        c(cell_pix_list)=cell_stack(cell_pix_list); 
re_c=reshape(crop_cell,[],size(cell_bw,2)*size(cell_bw,3)); 
                        
re_bw_c=reshape(bw_c,[],size(cell_bw,2)*size(cell_bw,3)); 
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                        out_img=[re_c;re_bw_c;]; 
                         
                        disp('img ready') 
%% All the stored data is stored in different variables on each object 
iteration 
                         
                        
out_cell_thresh_fac(all_obj_count)=cell_thresh_fac; 
                        %area 
                        out_cell_area(all_obj_count)=cell_area; 
                        %intensity 
                        out_cell_int(all_obj_count)=cell_int; 
                        % calculate nulcear/total intensity ratios 
                        
out_nuc_cell_ratio(all_obj_count)=out_nuc_int(all_obj_count)/out_cell_
int(all_obj_count); 
                        %avg int 
                        
out_avg_nuc_int(all_obj_count)=out_nuc_int(all_obj_count)/out_nuc_area
(all_obj_count); 
                        
out_avg_cell_int(all_obj_count)=out_cell_int(all_obj_count)/out_cell_a
rea(all_obj_count); 
                        %avg ratio 
                        
out_avg_ratio(all_obj_count)=out_avg_nuc_int(all_obj_count)/out_avg_ce
ll_int(all_obj_count); 
                        %% output image is written for each object 
                        imwrite(out_img,[img_write_path 'cell_' 
num2str(obj_count) '_img' num2str(img_count) '.jpg'],'jpg'); 
                        disp(['done writing image' 'cell_' 
num2str(obj_count) '_img' num2str(img_count)]) 
                        xls_label{all_obj_count+1,1}=['cell_' 
num2str(obj_count) '_img' num2str(img_count)]; 
                    end % for 3d area thresh 
                    %% clear var 
                    clear rat_member crop_smo_cell crop_cell crop_nuc 
crop_orig_cell crop_phos crop_orig_phos 
                end % for object 
                clear data 
                clear cell_stack orig_cell_stack 
                clear sum_cell sum_smooth_cell re_smooth_cell 
                 
            end % for if ~isempty(bw_re_prop) 
        end %for tot chanl check 
    end %for image 
    %     %% format data 
     
    % format data 
    %collects all data in one variable 
    final_data_out(:,2)=out_cell_int(:); 
     
    %sets header label for excel file 
    xls_label{1,3}='Cell Intensity'; 
     
 % write excel file 
    xls_file_name=[img_write_path, fold_list(fold_count).name '.xls']; 
    xlswrite(xls_file_name,xls_label,'Sheet1' );%write headers 
    xlswrite(xls_file_name,final_data_out,'Sheet1','B2' );%write 
values 
    disp('done writing excel file') 
    clear xls_label final_data_out out_* 
    clear nuc_avg_out nuc_all_out nuc_cumu_x out_cumu_nuc_int 
    clear cell_avg_out cell_all_out cell_cumu_x out_cumu_cell_int 
end %for folder 
% save([root_root 'nuc_ints.mat'], 'out_cumu_nuc_int') 
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6.2 R plotting program 
#clear all variables from R workspace 
rm(list=ls())  
############## 
#Variables to change before plotting 
#set path to root folder containing various folders with analysed images 
#and output excel sheets from MATLAB 
root<-"//paxillin data" 
#specify Sheet to read 
in_sheet_name<-"Sheet2" 
out_path<-file.path(root, paste("analysis",Sys.Date(),sep="")) 
 #labels for x and y axes 
x_axis_lbl<-"Nuclear/Total Intensity Ratio" 
y_axis_lbl<-c("WT Paxillin", "WT Paxillin\n+LMB"               
) 
#internal names for samples. this also determines how many folders to 
iterate over 
# folders are accessed in alphabetical order so folder names start with 
numbers 
#e.g. 1_name, 2_name.... 
sample_names<-c("wtpax", "wtpax.lmb" 
) 
#set font size for output plot 
out_font_size<-65 
 
######### 
#the code below makes and saves the plot 
#initialize libraries 
library(xlsx) # req to read excel files 
library(psych)# req for statistics 
library(reshape2)#req to melt 
library(ggplot2)# req for plotting 
source("C:/Users/Aneesh/Dropbox/Aneesh_R/functions/multiplot.R")#for 
laptop 
source("C:/Users/Aneesh/Dropbox/Aneesh_R/functions/summarySE.R")#for 
laptop 
 
###### 
### READ DATA 
 
fold_list<-dir(root) 
all_data<-data.frame() 
#below for loop iterates over all folders and reads data 
for(count in 1:length(y_axis_lbl)){ 
# autogenerate file path with suffix results_ 
  excel_path<-c(Sys.glob(file.path(root,fold_list[count], 
"results_*","*.xlsx", fsep = .Platform$file.sep),dirmark = TRUE)) 
  if (length(excel_path)!=0){ 
    pro_mydata <- read.xlsx(excel_path, sheetName=in_sheet_name)#for 
xls files 
  } 
  #melt data. this simplifies a wide table into a single column of 
values 
  colnames(pro_mydata)[1]<-sample_names[count] 
  names(pro_mydata)<-tolower(names(pro_mydata)) 
  pro_mydata.melt<-melt(pro_mydata, id=2:length(pro_mydata)) 
  #change colnames before rbind 
  colnames(pro_mydata.melt)[c(length(pro_mydata.melt)-
1):c(length(pro_mydata.melt))]<-c("sample","cellid") 
  #rbind is used to append new data with existing values in the varialbe 
all_data 
  all_data<-rbind(all_data,pro_mydata.melt) 
   
} 
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# summarize data 
#calculates statistics using summarySE for given variable, in this case 
ratio 
#they are grouped by sample names stored in 'sample' 
all_data.stats <- summarySE(all_data, measurevar="ratio", 
groupvars=c("sample")) 
all_data.stats$ratio<-signif(all_data.stats$ratio,digits=4) 
#################  
# Calculate p-values 
attach(all_data) 
p_val_out<-
pairwise.t.test(ratio,sample,p.adjust.method="holm",paired=FALSE, 
pool.sd=FALSE) 
detach() 
p_table<-signif(data.frame(p_val_out$p.value), digits = 4) 
#for easy interpretation all p values are converted to asterisk based 
output 
# single * for p<=0.05, ** for p<0.01 and *** for p<0.001 
p_star<-data.frame(matrix(NA, nrow = dim(p_table)[1], ncol = 
dim(p_table)[2])) 
p_star<-p_table 
names(p_star)<-names(p_table) 
row.names(p_star)<-row.names(p_table) 
p_star[p_table <= .05]  <- "*" 
p_star[p_table <= .01]  <- "**" 
p_star[p_table <= .001] <- "***" 
p_star_table<-p_star 
####### 
# PLOT of generated data 
#set x and y samples names to be used from all_data.stats 
out_plot2<-ggplot(all_data.stats,aes(x=sample,y=ratio, 
stat="identity", 
label=ratio))+ 
  geom_bar(alpha=0.5)+ #use bar plot   #actual plot 
  geom_errorbar(aes(ymax=ratio+se,ymin=ratio-
se),width=0.3,size=0.2)+#add error bars 
  scale_colour_grey()+ #set colour 
  #themes set other cosmetic parameters 
  theme_bw(base_size = out_font_size, base_family = "serif")+ 
  theme(legend.position = "none") + 
  #label x and y axes 
  ylab(x_axis_lbl)+ 
  xlab(NULL)+ 
  scale_x_discrete(breaks=c(levels(all_data$sample)),               
labels=y_axis_lbl)+ 
  coord_flip()# flip coordinates for easy reading of plot 
##### 
# Save plot 
dir.create(out_path)# create output folder 
#save all the analysis data in the output folder in the .RData format 
save.image(file = file.path(out_path, 
paste("RAnalysis",".RData",sep="") )) 
unlink(".RData") 
#save plot in desired format in this case .pdf for easy handling in 
adobe illustrator 
ggsave(file.path(out_path, paste("out_plot_bar",".pdf",sep="")),  
       plot =out_plot2, width = 40, height = 40) 
#save p value plot 
png(file.path(out_path, 
paste("out_p_table",".png",sep="")),width=1000,height=400, 
    type = "windows",bg = "transparent") 
print(grid.table(p_star_table, 
                 gpar.coretext=gpar(fontsize=24),  
                 gpar.coltext=gpar(fontsize=24,fontface = "bold"),  
                 gpar.rowtext=gpar(fontsize=24,fontface = "bold"))) 
dev.off() 
#### End of program 
